STOCK TITAN

Air Industries Group posts $946K Q3 profit

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
10-Q

Rhea-AI Filing Summary

AIR INDUSTRIES GROUP (AIRI) reported third-quarter net sales of $14.551 million, up 41.1% from $10.309 million, and net income of $946,000 versus a $44,000 loss a year earlier. Gross profit was $3.705 million, with a 25.5% margin versus 22.3%.

For the nine months ended September 30, 2026, sales rose 8.7% to $38.152 million, while net loss narrowed to $920,000 from $1.454 million. Operating cash flow was $783,000, compared with $754,000 used in the prior-year period. Unfilled contract values were $280.7 million as of September 30, including $141.4 million of funded backlog.

The company reported substantial doubt about its ability to continue as a going concern. Debt under its credit facility and related-party notes was approximately $28.697 million at September 30, 2026; those maturities were later extended to April 30 and May 1, 2027. A pending Tenax merger provides for 126,900,000 AIRI shares (25,380,000 after a proposed 1-for-5 reverse split); Tenax members would own approximately 96% after closing. The split is expected on November 20, 2026, subject to stockholder approval and charter-amendment effectiveness; merger closing depends on the HSR waiting period, listing of the merger shares and other conditions.

4 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

1 major · 1 point

How the balance works

Positive

  • Moderate pointQuarterly sales rose 41.1% to $14.551 million.
  • Moderate pointQuarterly net income reached $946,000, versus a $44,000 loss.
  • Moderate pointNine-month sales increased 8.7% to $38.152 million.
  • Moderate pointNine-month net loss narrowed 36.73% to $920,000.

Negative

  • Major pointGoing-concern doubt accompanies debt due April 30 and May 1, 2027.

Filing Explained

The related-party note amendments add a conditional cost: if the Tenax merger has not closed by November 30, 2026, principal increases 2% and, from December 1, 2026, interest resets to the greater of 12.5% or SOFR plus 8.5%, while default on principal or interest payments raises the rate to the greater of 24% or SOFR plus 15%.

Third-quarter net sales $14.551 million Three months ended September 30, 2026; up 41.1% from the same period in 2025.
Third-quarter net income $946,000 Three months ended September 30, 2026; compared with a $44,000 net loss in 2025.
Nine-month net sales $38.152 million Nine months ended September 30, 2026; up 8.7% from the same period in 2025.
Nine-month net loss ($920,000) Nine months ended September 30, 2026; compared with a $1.454 million loss in 2025.
Net cash provided by operating activities $783,000 Nine months ended September 30, 2026; compared with $754,000 used in the prior-year period.
Debt under credit facility and related-party notes Approximately $28.697 million As of September 30, 2026.
Unfilled contract values $280.7 million As of September 30, 2026; includes $141.4 million of funded backlog and potential orders under previously awarded LTAs.
Merger consideration 126,900,000 common shares (25,380,000 after the proposed 1-for-5 reverse split) Shares AIRI would issue to Tenax members at closing under the merger agreement.
going concern financial
"substantial doubt about the Company’s ability to continue as a going concern"
Going concern is the accounting assumption that a company will keep operating and meeting its obligations for the foreseeable future. The phrase matters most when a company or its auditors disclose substantial doubt about it, a formal warning that the business may not have enough resources to continue without raising money, restructuring, or selling assets. That language in a filing or press release signals elevated financial risk.
Fixed Charge Coverage Ratio financial
"minimum Fixed Charge Coverage Ratio (“FCCR”) of 1.10x"
A fixed charge coverage ratio measures how well a company's operating income can cover its fixed, recurring obligations like interest payments and lease costs. Think of it as a safety margin — the higher the number, the more comfortably a business can pay steady bills from its normal earnings, which matters to investors because it signals financial stability, lower default risk, and greater ability to withstand revenue dips.
funded backlog financial
"$141.4 million in funded backlog"
Funded backlog is the portion of a company’s unfulfilled orders or signed contracts that already has committed financing or approved budget behind it, meaning the customer (or a funding source) has promised the money needed to pay for the work. For investors it signals clearer near-term revenue visibility and lower execution risk — like a stack of paid-for jobs waiting to be finished rather than hopeful leads — which helps assess future cash flow and growth reliability.
Hart-Scott-Rodino Act regulatory
"waiting period under the Hart-Scott-Rodino Act"
A U.S. antitrust law that requires parties to large mergers and acquisitions to notify federal regulators and wait a set period before closing the deal, so authorities can check whether the transaction would unfairly reduce competition. For investors, the process is like notifying a referee before a major team trade: it can reveal objections, trigger investigations, delay or block a deal, and therefore affect transaction timing, value and deal risk.
Secured Overnight Financing Rate financial
"the Secured Overnight Financing Rate (“SOFR”) plus 8.5%"
A secured overnight financing rate (SOFR) is a daily benchmark interest rate that reflects the cost of borrowing cash overnight using U.S. Treasury securities as collateral. Think of it as the market price to “rent” cash for a day with a very safe pledge, similar to paying a short-term rental fee for money backed by government bonds. Investors track SOFR because it underpins pricing for loans, bonds and derivatives, so movements change borrowing costs, interest income and the valuation of interest-rate–linked positions.
At The Market Offering financial
"gross proceeds of $4,869,000 through an At The Market (“ATM”) Offering"
An at-the-market offering is a way a company raises cash by selling newly issued shares directly into the open market at prevailing prices, rather than all at once in a single deal. Think of it like turning a faucet on to drip shares into trading at current prices when needed; it gives the company flexibility to raise funds over time but can dilute existing shareholders and potentially affect the stock price, which investors should monitor.
Split Ratio 1-for-5 reverse split
Effective Date November 20, 2026
Shares Before Split 4,856,181
Share Count As Of September 30, 2026

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much revenue did AIRI report in the third quarter of 2026?

AIRI reported net sales of $14.551 million for the three months ended September 30, 2026, compared with $10.309 million in the same period of 2025, a 41.1% increase. The company attributed the increase primarily to changes in the mix of products delivered in response to customer orders.

Was AIRI profitable in the third quarter of 2026?

AIRI reported net income of $946,000 for the three months ended September 30, 2026, compared with a net loss of $44,000 in the same period of 2025. Gross profit was $3.705 million, and the company reported a gross margin of 25.5%, compared with 22.3% a year earlier.

What are the proposed AIRI-Tenax merger share terms?

The merger agreement provides for AIRI to issue 126,900,000 common shares to Tenax members, or 25,380,000 shares after the proposed 1-for-5 reverse split. Following closing, Tenax members would own approximately 96% and existing AIRI stockholders approximately 4%. Closing is subject to the HSR waiting period, listing of the merger shares and other conditions.

When is AIRI's reverse stock split expected to take effect?

The 1-for-5 reverse stock split is expected to become effective on November 20, 2026, subject to stockholder approval of the AIR Charter Amendment at the special meeting scheduled for November 18, 2026, and the amendment's effectiveness.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
NYSEAMER 0001009891 false Q3 --12-31 0.001 0.001 0.001 0.001 http://fasb.org/srt/2026#ChiefExecutiveOfficerMember 0001009891 2026-07-01 2026-09-30 0001009891 adtx:ARMergerAgreementMember 2026-01-01 2026-09-30 0001009891 adtx:ARMergerAgreementMember 2026-09-30 0001009891 adtx:ARMergerAgreementMember srt:MaximumMember 2026-09-30 0001009891 adtx:ARMergerAgreementMember srt:MinimumMember 2026-09-30 0001009891 us-gaap:CommonStockMember 2026-01-01 2026-09-30 0001009891 adtx:MergerAgreementMember 2026-01-01 2026-09-30 0001009891 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2026-09-30 0001009891 adtx:ARMergerAgreementMember us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2026-09-30 0001009891 us-gaap:CommonStockMember 2026-09-30 0001009891 2026-01-01 2026-09-30 0001009891 adtx:MergerAgreementMember 2026-06-02 0001009891 2021-07-08 2021-07-08 0001009891 2018-10-02 2018-10-02 0001009891 us-gaap:RestrictedStockUnitsRSUMember 2026-09-30 0001009891 us-gaap:RestrictedStockUnitsRSUMember 2026-01-01 2026-09-30 0001009891 us-gaap:RestrictedStockUnitsRSUMember adtx:GrantedTwoZeroTwoFourMember 2026-01-01 2026-09-30 0001009891 srt:BoardOfDirectorsChairmanMember 2025-01-01 2025-09-30 0001009891 srt:BoardOfDirectorsChairmanMember 2026-01-01 2026-09-30 0001009891 srt:BoardOfDirectorsChairmanMember 2025-07-01 2025-09-30 0001009891 srt:BoardOfDirectorsChairmanMember 2026-07-01 2026-09-30 0001009891 us-gaap:RestrictedStockUnitsRSUMember 2025-12-31 0001009891 us-gaap:RestrictedStockUnitsRSUMember 2025-01-01 2025-12-31 0001009891 us-gaap:RestrictedStockUnitsRSUMember 2024-12-31 0001009891 us-gaap:RestrictedStockUnitsRSUMember 2025-09-30 0001009891 2025-12-31 0001009891 2026-09-30 0001009891 us-gaap:StockOptionMember 2025-12-31 0001009891 us-gaap:StockOptionMember 2025-01-01 2025-12-31 0001009891 us-gaap:StockOptionMember 2026-09-30 0001009891 us-gaap:StockOptionMember 2026-01-01 2026-09-30 0001009891 us-gaap:StockOptionMember 2024-12-31 0001009891 2025-01-01 2025-09-30 0001009891 2025-07-01 2025-09-30 0001009891 srt:MaximumMember adtx:EquityIncentivePlan2022Member 2025-09-30 0001009891 srt:MinimumMember adtx:EquityIncentivePlan2022Member 2025-09-30 0001009891 adtx:EquityIncentivePlan2022Member 2025-09-30 0001009891 us-gaap:CommonStockMember us-gaap:RestrictedStockUnitsRSUMember 2026-04-01 2026-04-30 0001009891 us-gaap:CommonStockMember 2026-04-01 2026-04-30 0001009891 us-gaap:CommonStockMember srt:DirectorMember 2025-01-01 2025-09-30 0001009891 us-gaap:CommonStockMember srt:DirectorMember 2026-01-01 2026-09-30 0001009891 us-gaap:CommonStockMember srt:DirectorMember 2025-07-01 2025-09-30 0001009891 us-gaap:CommonStockMember srt:DirectorMember 2026-07-01 2026-09-30 0001009891 adtx:RelatedPartyIndebtednessMember 2026-01-01 2026-09-30 0001009891 adtx:ConvertibleSubordinatedNotesMember 2026-01-01 2026-09-30 0001009891 adtx:MichaelRobertTaglichBrothersIncMember adtx:AnnualRateSevenPercentagMember 2026-09-30 0001009891 us-gaap:CommonStockMember adtx:ConvertibleSubordinatedNotesMember 2026-09-30 0001009891 adtx:MichaelRobertTaglichBrothersIncMember adtx:AnnualInterestRateTwelvePercentageMember 2026-09-30 0001009891 adtx:MichaelRobertTaglichBrothersIncMember adtx:AnnualInterestRateSixPercentageMember 2026-09-30 0001009891 adtx:MichaelRobertTaglichBrothersIncMember 2026-09-30 0001009891 adtx:RobertTaglichDirectorMember 2026-09-30 0001009891 adtx:MichaelTaglichDirectorMember 2026-09-30 0001009891 adtx:TaglichBrothersMember adtx:MarketOfferingMember 2025-01-01 2025-09-30 0001009891 adtx:TaglichBrothersMember adtx:MarketOfferingMember 2025-07-01 2025-09-30 0001009891 adtx:MichaelTaglichMember adtx:MarketOfferingMember 2025-01-01 2025-09-30 0001009891 adtx:MichaelTaglichMember adtx:MarketOfferingMember 2025-07-01 2025-09-30 0001009891 adtx:MarketOfferingMember 2025-09-30 0001009891 adtx:MarketOfferingMember 2025-01-01 2025-09-30 0001009891 adtx:MarketOfferingMember 2025-07-01 2025-09-30 0001009891 adtx:MichaelRobertTaglichBrothersIncMember 2026-01-01 2026-09-30 0001009891 adtx:LoanObligationMember 2025-12-31 0001009891 2025-01-01 2025-12-31 0001009891 adtx:SolarCreditFacilityMember 2025-01-01 2025-09-30 0001009891 adtx:SolarCreditFacilityMember 2026-01-01 2026-09-30 0001009891 adtx:SolarCreditFacilityMember 2025-07-01 2025-09-30 0001009891 adtx:SolarCreditFacilityMember 2026-07-01 2026-09-30 0001009891 adtx:SolarCreditFacilityMember 2026-09-30 0001009891 adtx:SolarCreditFacilityMember adtx:ConnecticutGreenBankMember 2025-07-01 2025-07-01 0001009891 adtx:SolarCreditFacilityMember 2024-10-01 0001009891 adtx:SolarCreditFacilityMember 2024-10-01 2024-10-01 0001009891 adtx:SolarCreditFacilityMember adtx:ConnecticutGreenBankMember 2024-10-01 2024-10-01 0001009891 2023-08-16 0001009891 adtx:RevolvingLoanMember 2026-09-30 0001009891 adtx:ATMOfferingMember 2026-01-01 2026-09-30 0001009891 us-gaap:SubsequentEventMember 2026-11-09 0001009891 us-gaap:SubsequentEventMember 2026-11-09 2026-11-09 0001009891 2026-08-18 2026-08-18 0001009891 2026-02-26 0001009891 2026-02-26 2026-02-26 0001009891 2025-12-15 2025-12-15 0001009891 adtx:CurrentCreditFacilityMember 2025-09-10 2025-09-10 0001009891 2025-01-30 2025-01-30 0001009891 adtx:TermLoansMember 2025-01-30 0001009891 2025-01-30 0001009891 adtx:TermLoansMember 2025-01-30 2025-01-30 0001009891 adtx:CurrentCreditFacilityMember 2025-01-01 2025-09-30 0001009891 adtx:CurrentCreditFacilityMember 2026-01-01 2026-09-30 0001009891 adtx:CurrentCreditFacilityMember 2025-07-01 2025-09-30 0001009891 adtx:CurrentCreditFacilityMember 2026-07-01 2026-09-30 0001009891 adtx:RevolvingLineOfCreditMember 2026-09-30 0001009891 adtx:TermLoansMember 2026-09-30 0001009891 us-gaap:RevolvingCreditFacilityMember 2026-09-30 0001009891 adtx:TermLoansMember 2026-01-01 2026-09-30 0001009891 us-gaap:RevolvingCreditFacilityMember adtx:WebsterBankMember 2026-01-01 2026-09-30 0001009891 us-gaap:RevolvingCreditFacilityMember adtx:WebsterBankMember 2026-09-30 0001009891 adtx:CurrentCreditFacilityMember adtx:WebsterBankMember 2026-01-01 2026-09-30 0001009891 adtx:SolarCreditFacilityMember 2025-12-31 0001009891 adtx:CurrentCreditFacilityTermLoanMember 2025-12-31 0001009891 adtx:CurrentCreditFacilityTermLoanMember 2026-09-30 0001009891 us-gaap:RevolvingCreditFacilityMember 2025-12-31 0001009891 us-gaap:DebtMember 2025-12-31 0001009891 us-gaap:DebtMember 2026-09-30 0001009891 srt:ScenarioForecastMember 2027-01-01 2027-01-01 0001009891 2026-10-29 2026-10-29 0001009891 us-gaap:ComputerEquipmentMember srt:MaximumMember 2026-09-30 0001009891 us-gaap:ComputerEquipmentMember srt:MinimumMember 2026-09-30 0001009891 us-gaap:ComputerEquipmentMember 2025-12-31 0001009891 us-gaap:ComputerEquipmentMember 2026-09-30 0001009891 us-gaap:LeaseholdImprovementsMember 2025-12-31 0001009891 us-gaap:LeaseholdImprovementsMember 2026-09-30 0001009891 us-gaap:FurnitureAndFixturesMember srt:MaximumMember 2026-09-30 0001009891 us-gaap:FurnitureAndFixturesMember srt:MinimumMember 2026-09-30 0001009891 us-gaap:FurnitureAndFixturesMember 2025-12-31 0001009891 us-gaap:FurnitureAndFixturesMember 2026-09-30 0001009891 us-gaap:AutomobilesMember 2026-09-30 0001009891 us-gaap:AutomobilesMember 2025-12-31 0001009891 us-gaap:ToolsDiesAndMoldsMember srt:MaximumMember 2026-09-30 0001009891 us-gaap:ToolsDiesAndMoldsMember srt:MinimumMember 2026-09-30 0001009891 us-gaap:ToolsDiesAndMoldsMember 2025-12-31 0001009891 us-gaap:ToolsDiesAndMoldsMember 2026-09-30 0001009891 us-gaap:MachineryAndEquipmentMember srt:MaximumMember 2026-09-30 0001009891 us-gaap:MachineryAndEquipmentMember srt:MinimumMember 2026-09-30 0001009891 us-gaap:MachineryAndEquipmentMember 2025-12-31 0001009891 us-gaap:MachineryAndEquipmentMember 2026-09-30 0001009891 us-gaap:BuildingImprovementsMember 2026-09-30 0001009891 us-gaap:BuildingImprovementsMember 2025-12-31 0001009891 us-gaap:LandImprovementsMember 2025-12-31 0001009891 us-gaap:LandImprovementsMember 2026-09-30 0001009891 srt:DirectorMember 2025-01-01 2025-09-30 0001009891 srt:DirectorMember 2026-01-01 2026-09-30 0001009891 srt:DirectorMember 2025-07-01 2025-09-30 0001009891 srt:DirectorMember 2026-07-01 2026-09-30 0001009891 us-gaap:ShareBasedPaymentArrangementEmployeeMember 2025-07-01 2025-09-30 0001009891 us-gaap:ShareBasedPaymentArrangementEmployeeMember 2025-01-01 2025-09-30 0001009891 us-gaap:ShareBasedPaymentArrangementEmployeeMember 2026-01-01 2026-09-30 0001009891 us-gaap:ShareBasedPaymentArrangementEmployeeMember 2026-07-01 2026-09-30 0001009891 us-gaap:ConvertibleDebtSecuritiesMember 2025-01-01 2025-09-30 0001009891 us-gaap:ConvertibleDebtSecuritiesMember 2026-01-01 2026-09-30 0001009891 us-gaap:ConvertibleDebtSecuritiesMember 2025-07-01 2025-09-30 0001009891 us-gaap:RestrictedStockUnitsRSUMember 2025-01-01 2025-09-30 0001009891 us-gaap:RestrictedStockUnitsRSUMember 2026-01-01 2026-09-30 0001009891 us-gaap:RestrictedStockUnitsRSUMember 2025-07-01 2025-09-30 0001009891 us-gaap:StockOptionMember 2025-01-01 2025-09-30 0001009891 us-gaap:StockOptionMember 2026-01-01 2026-09-30 0001009891 us-gaap:StockOptionMember 2025-07-01 2025-09-30 0001009891 us-gaap:StockOptionMember 2026-07-01 2026-09-30 0001009891 us-gaap:CommercialRealEstateMember 2025-01-01 2025-09-30 0001009891 us-gaap:CommercialRealEstateMember 2026-01-01 2026-09-30 0001009891 us-gaap:CommercialRealEstateMember 2025-07-01 2025-09-30 0001009891 us-gaap:CommercialRealEstateMember 2026-07-01 2026-09-30 0001009891 adtx:MilitaryMember 2025-01-01 2025-09-30 0001009891 adtx:MilitaryMember 2026-01-01 2026-09-30 0001009891 adtx:MilitaryMember 2025-07-01 2025-09-30 0001009891 adtx:MilitaryMember 2026-07-01 2026-09-30 0001009891 us-gaap:CustomerConcentrationRiskMember adtx:LockheedMartinMember us-gaap:AccountsReceivableMember 2025-01-01 2025-12-31 0001009891 us-gaap:CustomerConcentrationRiskMember adtx:LockheedMartinMember us-gaap:AccountsReceivableMember 2026-01-01 2026-09-30 0001009891 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember adtx:FokkerMember 2025-01-01 2025-12-31 0001009891 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember adtx:FokkerMember 2026-01-01 2026-09-30 0001009891 us-gaap:CustomerConcentrationRiskMember adtx:RTXMember us-gaap:AccountsReceivableMember 2025-01-01 2025-12-31 0001009891 us-gaap:CustomerConcentrationRiskMember adtx:RTXMember us-gaap:AccountsReceivableMember 2026-01-01 2026-09-30 0001009891 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember adtx:GeneralElectricMember 2025-01-01 2025-12-31 0001009891 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember adtx:GeneralElectricMember 2026-01-01 2026-09-30 0001009891 us-gaap:CustomerConcentrationRiskMember adtx:LockheedMartinMember us-gaap:SalesRevenueNetMember 2025-01-01 2025-09-30 0001009891 us-gaap:CustomerConcentrationRiskMember adtx:LockheedMartinMember us-gaap:SalesRevenueNetMember 2026-01-01 2026-09-30 0001009891 us-gaap:CustomerConcentrationRiskMember adtx:RTXMember us-gaap:SalesRevenueNetMember 2025-01-01 2025-09-30 0001009891 us-gaap:CustomerConcentrationRiskMember adtx:RTXMember us-gaap:SalesRevenueNetMember 2026-01-01 2026-09-30 0001009891 us-gaap:CustomerConcentrationRiskMember adtx:LockheedMartinMember us-gaap:SalesRevenueNetMember 2025-07-01 2025-09-30 0001009891 us-gaap:CustomerConcentrationRiskMember adtx:LockheedMartinMember us-gaap:SalesRevenueNetMember 2026-07-01 2026-09-30 0001009891 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember adtx:TransaeroMember 2026-07-01 2026-09-30 0001009891 us-gaap:CustomerConcentrationRiskMember adtx:RTXMember us-gaap:SalesRevenueNetMember 2025-07-01 2025-09-30 0001009891 us-gaap:CustomerConcentrationRiskMember adtx:RTXMember us-gaap:SalesRevenueNetMember 2026-07-01 2026-09-30 0001009891 2025-09-30 0001009891 2024-12-31 0001009891 adtx:LongTermAgreementsMember 2026-09-30 0001009891 adtx:ATMOfferingMember 2025-01-01 2025-12-31 0001009891 adtx:CurrentCreditFacilityMember 2026-09-30 0001009891 us-gaap:RetainedEarningsMember 2025-09-30 0001009891 us-gaap:AdditionalPaidInCapitalMember 2025-09-30 0001009891 us-gaap:CommonStockMember 2025-09-30 0001009891 us-gaap:RetainedEarningsMember 2025-07-01 2025-09-30 0001009891 us-gaap:AdditionalPaidInCapitalMember 2025-07-01 2025-09-30 0001009891 us-gaap:CommonStockMember 2025-07-01 2025-09-30 0001009891 2025-06-30 0001009891 us-gaap:RetainedEarningsMember 2025-06-30 0001009891 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0001009891 us-gaap:CommonStockMember 2025-06-30 0001009891 2025-04-01 2025-06-30 0001009891 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0001009891 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0001009891 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0001009891 2025-03-31 0001009891 us-gaap:RetainedEarningsMember 2025-03-31 0001009891 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001009891 us-gaap:CommonStockMember 2025-03-31 0001009891 2025-01-01 2025-03-31 0001009891 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001009891 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001009891 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001009891 us-gaap:RetainedEarningsMember 2024-12-31 0001009891 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001009891 us-gaap:CommonStockMember 2024-12-31 0001009891 us-gaap:RetainedEarningsMember 2026-09-30 0001009891 us-gaap:AdditionalPaidInCapitalMember 2026-09-30 0001009891 us-gaap:RetainedEarningsMember 2026-07-01 2026-09-30 0001009891 us-gaap:AdditionalPaidInCapitalMember 2026-07-01 2026-09-30 0001009891 us-gaap:CommonStockMember 2026-07-01 2026-09-30 0001009891 2026-06-30 0001009891 us-gaap:RetainedEarningsMember 2026-06-30 0001009891 us-gaap:AdditionalPaidInCapitalMember 2026-06-30 0001009891 us-gaap:CommonStockMember 2026-06-30 0001009891 2026-04-01 2026-06-30 0001009891 us-gaap:RetainedEarningsMember 2026-04-01 2026-06-30 0001009891 us-gaap:AdditionalPaidInCapitalMember 2026-04-01 2026-06-30 0001009891 us-gaap:CommonStockMember 2026-04-01 2026-06-30 0001009891 2026-03-31 0001009891 us-gaap:RetainedEarningsMember 2026-03-31 0001009891 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001009891 us-gaap:CommonStockMember 2026-03-31 0001009891 2026-01-01 2026-03-31 0001009891 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0001009891 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0001009891 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0001009891 us-gaap:RetainedEarningsMember 2025-12-31 0001009891 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001009891 us-gaap:CommonStockMember 2025-12-31 0001009891 us-gaap:RelatedPartyMember 2025-12-31 0001009891 us-gaap:RelatedPartyMember 2026-09-30 0001009891 2026-11-12 0001009891 us-gaap:RestrictedStockUnitsRSUMember 2026-07-01 2026-09-30 0001009891 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember adtx:TransaeroMember 2025-07-01 2025-09-30 0001009891 us-gaap:ConvertibleDebtSecuritiesMember 2026-07-01 2026-09-30 0001009891 adtx:TaglichBrothersIncMember 2026-09-30 xbrli:shares xbrli:pure iso4217:USD xbrli:shares iso4217:USD adtx:segments

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

☒ Quarterly Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the quarterly period ended: September 30, 2026

 

or

 

☐ Transition Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the transition period from ______ to_______ 

 

Commission File No. 001-35927

 

AIR INDUSTRIES GROUP

(Exact name of registrant as specified in its charter)

 

Nevada   80-0948413
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification No.)

 

1460 Fifth Avenue, Bay Shore, New York 11706

(Address of principal executive offices)

 

(631) 968-5000

(Registrant’s telephone number, including area code)

 

Securities Registered pursuant to Section 12(b) of the Act

 

Title of Each Class   Trading Symbol(s)   Name of each Exchange on which Registered
Common Stock   AIRI   NYSE-American

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large Accelerated Filer ☐ Non-Accelerated Filer ☒
Accelerated Filer ☐ Smaller Reporting Company ☒
  Emerging Growth Company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

 

Indicate by check mark whether registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

 

There were 4,856,181 shares of the registrant’s common stock outstanding as of November 12, 2026. 

 

 

 

 

INDEX

 

    Page No.
PART I. FINANCIAL INFORMATION 2
   
Item 1. Financial Statements 2
   
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 23
   
Item 4. Controls and Procedures 33
   
PART II.  OTHER INFORMATION 34
   
Item 1A.  Risk Factors 34
     
Item 6. Exhibits 34
   
SIGNATURES 35

 

i

 

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This Quarterly Report on Form 10-Q filed by Air Industries Group (herein referred to as “Air Industries”, the “company”, “we”, “us”, or “our”) contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, or Securities Act, and Section 21E of the Securities Exchange Act of 1934, or Exchange Act. Certain of the matters discussed herein concerning, among other items, our operations, cash flows, financial position and economic performance including, in particular, future sales, product demand, competition and the effect of economic conditions, include forward-looking statements.

 

Forward-looking statements are predictive in nature and can be identified by the fact that they do not relate strictly to historical or current facts and generally include words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “estimates” and similar expressions. Although we believe that these statements are based upon reasonable assumptions, including projections of orders, sales, operating margins, earnings, cash flow, research and development costs, working capital, capital expenditures, distribution channels, profitability, new products, adequacy of funds from operations, and general economic conditions, these statements and other projections contained herein expressing opinions about future outcomes and non-historical information, are subject to uncertainties and, therefore, there is no assurance that the outcomes expressed in these statements will be achieved.

 

Investors are cautioned that forward-looking statements are not guarantees of future performance and actual results or developments may differ materially from the expectations expressed in forward-looking statements contained herein. Given these uncertainties, you should not place any reliance on these forward-looking statements which speak only as of the date hereof. Factors that could cause actual results to differ materially from those reflected in the forward-looking statements include, but are not limited to, those discussed under the heading “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2025, our Registration Statement on Form S-4 as amended on October 22, 2026 and declared effective on November 4, 2026, and elsewhere in this report and the risks discussed in our other filings with the Securities and Exchange Commission (“SEC”).

 

We do not intend to update or revise publicly and undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. You are advised, however, to review any additional disclosures we make in our reports filed with the SEC.

 

ii

 

PART I

 

FINANCIAL INFORMATION

 

    Page No.
Item 1. Financial statements   2
     
Condensed Consolidated Financial Statements:   2 
     
Condensed Consolidated Balance Sheets as of September 30, 2026 (unaudited) and December 31, 2025   2
     
Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2026 and 2025 (unaudited)   3
     
Condensed Consolidated Statements of Changes in Stockholders’ Equity for the three and nine months ended September 30, 2026 and 2025 (unaudited)   4
     
Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2026 and 2025 (unaudited)   5
     
Notes to Condensed Consolidated Financial Statements   7

 

1

 

Part I. Financial Information 

Item 1. Financial Statements

 

AIR INDUSTRIES GROUP

 

Condensed Consolidated Balance Sheets

 

    September 30,     December 31,  
    2026     2025  
    (unaudited)        
ASSETS            
Current Assets            
Cash   $ 702,000     $ 680,000  
Restricted cash     3,930,000       3,930,000  
Accounts Receivable, Net of Allowance for Credit Losses of $625,000 and $464,000     7,259,000       7,071,000  
Inventory     36,207,000       34,261,000  
Prepaid Expenses and Other Current Assets     457,000       766,000  
Prepaid Taxes     95,000       76,000  
Total Current Assets     48,650,000       46,784,000  
                 
Property and Equipment, Net     8,181,000       9,501,000  
Finance Lease Right-Of-Use-Assets     769,000       916,000  
Operating Lease Right-Of-Use-Assets     -       514,000  
Deferred Financing Costs, Net, Deposits and Other Assets     559,000       614,000  
                 
TOTAL ASSETS   $ 58,159,000     $ 58,329,000  
                 
LIABILITIES AND STOCKHOLDERS’ EQUITY                
Current Liabilities                
Debt   $ 24,006,000     $ 23,721,000  
Accounts Payable and Accrued Expenses     6,896,000       7,903,000  
Subordinated Notes - Related Party     4,871,000       4,871,000  
Operating Lease Liabilities     -       702,000  
Deferred Gain on Sale     -       28,000  
Customer Deposits     1,920,000       391,000  
Total Current Liabilities     37,693,000       37,616,000  
                 
Long Term Liabilities                
Debt     1,368,000       1,512,000  
TOTAL LIABILITIES     39,061,000       39,128,000  
                 
Commitments and Contingencies (see Note 8)                
                 
Stockholders’ Equity                
Preferred Stock - par value $.001 - Authorized 3,000,000 shares, 0 shares outstanding, at both September 30, 2026 and December 31, 2025.     -       -  
Common Stock - Par Value $.001 - Authorized 20,000,000 shares, 4,856,181 and 4,776,454 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively     5,000       5,000  
Additional Paid-In Capital     90,425,000       89,608,000  
Accumulated Deficit     (71,332,000 )     (70,412,000 )
TOTAL STOCKHOLDERS’ EQUITY     19,098,000       19,201,000  
                 
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY   $ 58,159,000     $ 58,329,000  

 

See accompanying notes to condensed consolidated financial statements

 

2

 

AIR INDUSTRIES GROUP


Condensed Consolidated Statements of Operations

For the Three and Nine Months Ended September 30,
(Unaudited)

 

    Three Months Ended     Nine Months Ended  
    September 30,     September 30,  
    2026     2025     2026     2025  
                         
Net Sales   $ 14,551,000     $ 10,309,000     $ 38,152,000     $ 35,111,000  
                                 
Cost of Sales     10,846,000       8,014,000       29,362,000       28,754,000  
                                 
Gross Profit     3,705,000       2,295,000       8,790,000       6,357,000  
                                 
Operating Expenses     2,406,000       1,979,000       8,422,000       6,779,000  
                                 
Income (Loss) from Operations     1,299,000       316,000       368,000       (422,000 )
                                 
Interest Expense     (401,000 )     (380,000 )     (1,225,000 )     (1,083,000 )
                                 
Interest Expense - Related Parties     (85,000 )     (86,000 )     (257,000 )     (271,000 )
                                 
Other Income, Net     133,000       106,000       212,000       322,000  
                                 
Income (Loss) before Income Taxes     946,000       (44,000 )     (902,000 )     (1,454,000 )
                                 
Provision for Income Taxes     -       -       18,000       -  
                                 
Net Income (Loss)   $ 946,000     $ (44,000 )   $ (920,000 )   $ (1,454,000 )
                                 
Net Income (Loss) per share - Basic   $ 0.19     $ (0.01 )   $ (0.19 )   $ (0.36 )
Net Income (Loss) per share - Diluted   $ 0.19     $ (0.01 )   $ (0.19 )   $ (0.36 )
Weighted Average Shares Outstanding - Basic     4,852,759       4,146,724       4,822,643       4,028,696  
Weighted Average Shares Outstanding - Diluted     5,505,558       4,146,724       4,822,643       4,028,696  

 

See accompanying notes to condensed consolidated financial statements

 

3

 

AIR INDUSTRIES GROUP

 

Condensed Consolidated Statements of Changes in Stockholders’ Equity 

For the Three and Nine Months Ended September 30, 2026 and 2025

(Unaudited)

 

                Additional           Total  
    Common Stock     Paid-in     Accumulated     Stockholders’  
    Shares     Amount     Capital     Deficit     Equity  
Balance January 1, 2026     4,776,454     $ 5,000     $ 89,608,000     $ (70,412,000 )   $ 19,201,000  
Common Stock issued to directors     4,600       -       14,000       -       14,000  
Stock-Based Compensation     -       -       950,000       -       950,000  
Net Loss     -       -       -       (1,020,000 )     (1,020,000 )
Balance, March 31, 2026     4,781,054     $ 5,000     $ 90,572,000     $ (71,432,000 )   $ 19,145,000  
                                         
Common Stock issued to directors     4,484       -       14,000       -       14,000  
Stock-Based Compensation     -       -       45,000       -       45,000  
Stock-Based Compensation forfeiture adjustment     -       -       (125,000 )     -       (125,000 )
Common Stock issued upon settlement of restricted stock units, net     65,120       -       (131,000 )     -       (131,000 )
Net Loss     -       -       -       (846,000 )     (846,000 )
Balance, June 30, 2026     4,850,658     $ 5,000     $ 90,375,000     $ (72,278,000 )   $ 18,102,000  
                                         
Common Stock issued to directors     5,523       -       14,000       -       14,000  
Stock-Based Compensation     -       -       36,000       -       36,000  
Net Income     -       -       -       946,000       946,000  
Balance, September 30, 2026     4,856,181     $ 5,000     $ 90,425,000     $ (71,332,000 )   $ 19,098,000  
                                         
Balance January 1, 2025     3,474,970     $ 3,000     $ 84,052,000     $ (69,107,000 )   $ 14,948,000  
Common Stock issued to directors     9,185       -       39,000       -       39,000  
Stock-Based Compensation     -       -       435,000       -       435,000  
Common Stock issued for cash     209,940       1,000       854,000       -       855,000  
Net Loss     -       -       -       (988,000 )     (988,000 )
Balance, March 31, 2025     3,694,095     $ 4,000     $ 85,380,000     $ (70,095,000 )   $ 15,289,000  
                                         
Common Stock issued to directors     12,950       -       39,000       -       39,000  
Stock-Based Compensation     -       -       157,000       -       157,000  
Common Stock issued for cash     97,866       -       330,000       -       330,000  
Common Stock issued upon settlement of restricted stock units, net     57,192       -       (127,000 )     -       (127,000 )
Net Loss     -       -       -       (422,000 )     (422,000 )
Balance, June 30, 2025     3,862,103     $ 4,000     $ 85,779,000     $ (70,517,000 )   $ 15,266,000  
                                         
Common Stock issued to directors     4,064       -       14,000       -       14,000  
Stock-Based Compensation     -       -       152,000       -       152,000  
Common Stock issued for cash     905,787       1,000       3,454,000       -       3,455,000  
Net Loss     -       -       -       (44,000 )     (44,000 )
Balance, September 30, 2025     4,771,954     $ 5,000     $ 89,399,000     $ (70,561,000 )   $ 18,843,000  

 

See accompanying notes to condensed consolidated financial statements

 

4

 

AIR INDUSTRIES GROUP

 

Condensed Consolidated Statements of Cash Flows
For the Nine Months Ended September 30,
(Unaudited)

 

    2026     2025  
             
CASH FLOWS FROM OPERATING ACTIVITIES            
Net Loss   $ (920,000 )   $ (1,454,000 )
Adjustments to reconcile net loss to net cash provided by operating activities                
Depreciation of property and equipment     2,091,000       1,814,000  
Stock-based compensation     1,073,000       836,000  
Stock-Based Compensation forfeiture adjustment     (125,000 )     -  
Amortization of Finance Lease Right-of-Use Assets     147,000       147,000  
Amortization of Operating Lease Right-of-Use Assets     514,000       514,000  
Deferred gain on sale     (28,000 )     (29,000 )
Gain on sale of equipment     -       (68,000 )
Allowance for credit losses     160,000       20,000  
Amortization of deferred financing costs     1,000       51,000  
Changes in Operating Assets and Liabilities                
(Increase) Decrease in Operating Assets:                
Accounts receivable     (348,000 )     2,135,000  
Inventory     (1,946,000 )     (5,616,000 )
Prepaid expenses and other current assets     309,000       (138,000 )
Contract costs receivable     -       296,000  
Prepaid taxes     (19,000 )     (20,000 )
Deposits and other assets     54,000       46,000  
Increase (Decrease) in Operating Liabilities:                
Accounts payable and accrued expenses     (1,007,000 )     2,043,000  
Operating lease liabilities     (702,000 )     (658,000 )
Customer deposits     1,529,000       (673,000 )
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES     783,000       (754,000 )
                 
CASH FLOWS FROM INVESTING ACTIVITIES                
Purchase of property and equipment     (771,000 )     (3,018,000 )
Proceed from sale of equipment     -       200,000  
NET CASH USED IN INVESTING ACTIVITIES     (771,000 )     (2,818,000 )
                 
CASH FLOWS FROM FINANCING ACTIVITIES                
Note payable - revolver - net - Current Credit Facility     1,139,000       2,933,000  
Proceeds from term loan - Current Credit Facility     -       1,640,000  
Proceeds from Common Stock issued for cash     -       4,640,000  
Payments for taxes related to net share settlement of equity awards     (131,000 )     (127,000 )
Payments of Subordinated Notes - related party     -       (1,291,000 )
Payments of term loan - Current Credit Facility     (786,000 )     (747,000 )
Payments of Solar Credit Facility     (28,000 )     -  
Payments of finance lease obligations     (179,000 )     (166,000 )
Payments of loan payable - financed asset     (5,000 )     (7,000 )
NET CASH PROVIDED BY FINANCING ACTIVITIES     10,000       6,875,000  
                 
NET INCREASE IN CASH     22,000       3,303,000  
CASH AT BEGINNING OF PERIOD     4,610,000       753,000  
CASH AT END OF PERIOD   $ 4,632,000     $ 4,056,000  

 

See accompanying notes to condensed consolidated financial statements

 

5

 

AIR INDUSTRIES GROUP

 

Condensed Consolidated Statements of Cash Flows (Continued)

For the Nine Months Ended September 30,

(Unaudited)

 

    2026     2025  
             
Supplemental cash flow information:            
Cash paid during the period for interest   $ 1,495,000     $ 1,310,000  
Cash paid during the period for taxes   $ 18,000     $ 19,000  
                 
Supplemental disclosure of non-cash investing and financing activities:                
    $ -     $ -  

 

See accompanying notes to condensed consolidated financial statements

 

6

 

AIR INDUSTRIES GROUP

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Note 1. ORGANIZATION AND BASIS OF PRESENTATION

 

Organization

 

Air Industries Group is a Nevada corporation (“AIRI”).  The accompanying condensed consolidated financial statements presented are those of AIRI, and its wholly-owned subsidiaries: Air Industries Machining Corp. (“AIM”), Nassau Tool Works, Inc. (“NTW”), and the Sterling Engineering Corporation (“Sterling”) (together, the “Company”).

 

Basis of Presentation

 

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information and with Rule 8-03 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and nine months ended September 30, 2026 are not necessarily indicative of the results that may be expected for the year ending December 31, 2026. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, as filed with the Securities and Exchange Commission on March 27, 2026, from which the accompanying condensed consolidated balance sheet dated December 31, 2025 was derived.

 

Going Concern and Management’s Plan

 

As of September 30, 2026, the Company was in compliance with its minimum Fixed Charge Coverage Ratio (“FCCR”) of 1.10x as of the last day of the Fiscal Quarter on a rolling twelve-month basis, having attained a ratio of 1.30x. Additionally, all other financial and business covenants required under the terms of the Current Credit Facility were met. The Company’s debt under its Current Credit Facility and Related Party Subordinated Notes approximates $28,697,000. The Current Credit Facility was amended on November 9, 2026 to extend the date on which it is scheduled to expire to April 30, 2027, and the Related Party Subordinated Notes were amended so that they now mature on May 1, 2027. These obligations are classified as current liabilities on the consolidated balance sheets as of September 30, 2026. As a result of the expiration dates of the Current Credit Facility and Related Party Subordinated Notes, there is substantial doubt about the Company’s ability to continue as a going concern for the twelve months following the date of filing of these condensed consolidated financial statements. The terms of all outstanding indebtedness are discussed further in “Note 5. Debt”.

 

The Company is actively engaged in constructive discussions with various lenders as the Company has been advised by its lender that it does not want to renew its Current Credit Facility for a period of one or more years. Nevertheless, Webster Bank has agreed to multiple short term extensions of the expiration date of the Current Credit Facility, most recently until April 30, 2027. The Company is currently seeking to find a new lender to replace its Current Credit Facility and remains engaged in discussions with Webster Bank as well as the holders of the Related Party Notes as to the terms and conditions on which they will further extend the maturity date of the Current Credit Facility beyond April 30, 2027 and the maturity date of the Related Pary Notes beyond May 1, 2027. While these discussions have been professional and remain ongoing, there can be no assurance that agreements will be reached with Webster Bank, the holders of the Related Party Notes or alternative financing sources to enable the Company to secure longer term debt financing.

 

To support current operations and strategic initiatives, the Company has raised capital through public market sales of its common stock since December 2024 and believes it can continue to access equity markets in future periods. During the year ended December 31, 2025, the Company generated gross proceeds of $4,869,000 through an At The Market (“ATM”) Offering, of which approximately $3,930,000 is restricted for the benefit of the Current Credit Facility lender. In light of the entry into the Merger Agreement with Tenax (each as defined in “Note 11. Merger Information”), the Company has temporarily paused all equity raising activity. See “Note 11. Merger Information”.

 

7

 

As of September 30, 2026, the Company had total unfilled contract values amounting to $280.7 million (including its $141.4 million in funded backlog) plus additional potential orders under previously awarded Long-Term Agreements (“LTAs”). These unfilled contract values support a positive outlook for future growth.

 

The Company generally sources its raw material, principally metal casting or forgings, from domestic sources. As such, the Company is generally not exposed to increased prices on imports but would be subject to increased prices if proposed tariffs or disruptions in supply chains resulting from tariffs or other geopolitical events or inflationary pressures cause the general level of prices for its products to increase. One component used by the Company on a key commercial aviation program is sourced from China. The Company’s contract with its customer for the product requires the Company to absorb the first five percent (5%) of any cost increases with further increases absorbed by the customer.

 

A substantial portion of the Company’s products are used in United States military aviation and as such, changes in the US defense budget are more material to demand than to changes in general economic conditions. However, the Company does have significant exposure in commercial aviation; demand for these products may be reduced if general economic conditions deteriorate reducing demand for commercial air travel.

 

The accompanying consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded assets or the classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

 

Note 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Accounts Receivable

 

Accounts receivable are carried at the original invoice amount less an estimate made for credit losses based on a review of all outstanding amounts on a quarterly basis. Management determines the allowance for credit losses by regularly evaluating individual customer receivables and considering a customer’s financial condition, credit history, current economic conditions and other relevant factors, including specific reserves for certain accounts. Accounts receivable are written off when deemed uncollectible.  Bad debt expenses are recorded in operating expenses on the condensed consolidated statements of operations.

 

The activity for the allowance for credit losses during the nine months ended September 30, 2026 and 2025 is set forth in the table below:

 

    Balance at           Deductions     Balance at  
    Beginning of     Charged to     from the     End of  
    Period     Expenses     Allowance     Period  
Nine Months ended September 30, 2026 Allowance for Credit Losses   $ 464,000     $ 239,000     $ (78,000 )   $ 625,000  
Nine Months ended September 30, 2025 Allowance for Credit Losses   $ 396,000     $ 76,000     $ (96,000 )   $ 376,000  

 

Inventory Valuation

 

The Company values inventory at the lower of cost or an estimated net realizable value using the first-in first-out method. The Company periodically evaluates inventory items not secured by backlog and establishes write-downs to estimated net realizable value for excess quantities, slow-moving goods, obsolescence and for other impairments of value. Adjustments to inventory are recorded in cost of sales.

 

8

 

Inventories consist of the following at:

 

    September 30,     December 31,  
    2026     2025  
             
Raw Materials   $ 6,483,000     $ 7,306,000  
Work In Progress     19,502,000       17,072,000  
Semi-Finished Goods     8,972,000       9,206,000  
Final-Finished Goods     1,250,000       677,000  
Total Inventory   $ 36,207,000     $ 34,261,000  

 

Credit and Concentration Risks

 

A large percentage of the Company’s revenues are derived directly from large aerospace and defense prime contractors for which the ultimate end-user is the U.S. Government, other governments, or commercial airlines. 

 

The composition of customers that exceeded 10% of net sales for the three months ended September 30, 2026 and 2025 are shown below:

 

  Percentage of Net Sales  
Customer   2026     2025  
RTX (a)     29.3 %     38.2 %
Transaero     22.5 %     -  
Lockheed Martin     14.6 %     30.2 %

 

(a) RTX includes Collins Landing Systems and Collins Aerostructures

 

The composition of customers that exceeded 10% of net sales for the nine months ended September 30, 2026 and 2025 are shown below:

 

  Percentage of Net Sales  
Customer   2026     2025  
RTX (a)     27.8 %     37.1 %
Lockheed Martin     24.9 %     32.5 %

 

(a) RTX includes Collins Landing Systems and Collins Aerostructures

 

The composition of customers that exceed 10% of accounts receivable at September 30, 2026 and December 31, 2025 are shown below:

 

    Percentage of
Net Receivables
 
    September 30,     December 31,  
Customer   2026     2025  
General Electric     22.2 %     6.9 %
RTX (a)     21.5 %     39.8 %
Fokker     14.0 %     7.2 %
Lockheed Martin     8.8 %     11.9 %

 

(a) RTX includes Collins Landing Systems and Collins Aerostructures

 

9

 

Disaggregation of Revenue

  

The following table summarizes revenue from contracts with customers for the three and nine months ended September 30, 2026 and 2025:

 

    Three Months Ended     Nine Months Ended  
Product   September 30, 2026     September 30, 2025     September 30, 2026     September 30, 2025  
                         
Military   $ 9,566,000     $ 5,377,000     $ 25,375,000     $ 20,549,000  
Commercial     4,985,000       4,932,000       12,777,000       14,562,000  
                                 
Total   $ 14,551,000     $ 10,309,000     $ 38,152,000     $ 35,111,000  

 

Cash

 

During the period ended September 30, 2026, the Company had occasionally maintained balances in its bank accounts that were in excess of the FDIC limit. The Company has not experienced any losses on these accounts. 

 

Major Suppliers

 

The Company utilizes sole-source suppliers to supply raw materials or other parts used in production. These suppliers are its only source for such parts and, therefore, in the event any of them were to go out of business or be unable to provide parts for any reason, the Company’s business would be severely harmed.

 

Customer Deposits

 

The Company receives advance payments on certain contracts with the remainder of the contract balance due upon the shipment of the final product once the customer inspects and approves the product for shipment. At that time, the entire amount will be recognized as revenue and the deposit will be applied to the customer’s invoice.

 

At September 30, 2026 and December 31, 2025, customer deposits were $1,920,000 and $391,000 respectively. The Company recognized revenue of $80,000 and $231,000 during the three and nine months ended September 30, 2026, respectively, that was included in the customer deposits balance as of December 31, 2025. The Company recognized revenue of $0 and $673,000 during the three and nine months ended September 30, 2025, respectively, that was included in the customer deposits balance as of December 31, 2024.

 

Backlog

 

Backlog represents the value of orders received pursuant to our Long-Term Agreements (“LTA”) or spot orders pursuant to a purchase order. As of September 30, 2026, backlog relating to remaining performance obligations on contracts was approximately $141.4 million. The Company estimates that a substantial portion of this backlog will be recognized as net sales during the next twenty-four months, with the rest thereafter. This expectation assumes that raw material supplies and outsourced processing is completed and delivered on time and that the Company’s customers will accept delivery as scheduled. The Company anticipates that sales during the aforementioned periods will also include sales from expected new orders that are not included in backlog.

 

Earnings (Loss) per Share

 

Basic earnings (loss) per share (“EPS”) is computed by dividing the net income (loss) applicable to common stock by the weighted-average number of shares of common stock outstanding for the period.

 

For purposes of calculating diluted earnings (loss) per common share, the numerator includes net income (loss) plus interest on convertible notes payable assumed converted as of the first day of the period. The denominator includes both the weighted-average number of shares of common stock outstanding during the period and the number of common stock equivalents if the inclusion of such common stock equivalents is dilutive. Dilutive common stock equivalents potentially include stock options, RSUs and warrants using the treasury stock method and convertible notes payable using the if-converted method.

 

10

 

The following is the calculation of net income (loss) applicable to common shareholders utilized to calculate the EPS:

 

    Three Months Ended     Nine Months Ended  
    September 30,     September 30,     September 30,     September 30,  
    2026     2025     2026     2025  
                         
Net Income (Loss) per condensed consolidated statements of operations   $ 946,000     $ (44,000 )   $ (920,000 )   $ (1,454,000 )
Add: Convertible Note Interest for Potential Note Conversion     77,000       -       -       -  
Net Income (Loss) used to calculate diluted earnings per share   $ 1,023,000     $ (44,000 )   $ (920,000 )   $ (1,454,000 )

 

    Three Months Ended     Nine Months Ended  
    September 30,     September 30,     September 30,     September 30,  
    2026     2025     2026     2025  
Per share amount - basic   $ 0.19     $ (0.01 )   $ (0.19 )   $ (0.36 )
Per share amount - diluted   $ 0.19     $ (0.01 )   $ (0.19 )   $ (0.36 )

 

The following is a reconciliation of the denominators of basic and diluted earnings per share computations:

 

    Three Months Ended     Nine Months Ended  
    September 30,     September 30,     September 30,     September 30,  
    2026     2025     2026     2025  
                         
Weighted average shares outstanding used to compute basic earnings per share     4,852,759       4,146,724       4,822,643       4,028,696  
Effect of dilutive restricted stock units     291,099       -       -       -  
Effect of dilutive convertible notes payable     361,700       -       -       -  
Weighted average shares outstanding and dilutive securities used to compute dilutive earnings per share     5,505,558       4,146,724       4,822,643       4,028,696  

 

The following securities have been excluded from the diluted earnings per share calculation because their effect would have been anti-dilutive. Stock options were excluded, as applicable, because their exercise prices exceeded the average market price of the Company’s common stock during the respective periods. Potential common shares were also excluded from periods in which the Company reported a net loss because their inclusion would have been anti-dilutive.

 

    Three Months Ended     Nine Months Ended  
    September 30,     September 30,     September 30,     September 30,  
    2026     2025     2026     2025  
                         
Stock Options     263,953       373,103       263,953       373,103  
Restricted Stock Units     -       190,418       291,099       190,418  
Convertible Notes Payable     -       361,700       361,700       361,700  
      263,953       925,221       916,752       925,221  

 

Stock-Based Compensation

 

The Company accounts for stock-based compensation in accordance with FASB ASC 718, “Compensation – Stock Compensation.” Under the fair value recognition provision of the ASC, stock-based compensation cost is estimated at the grant date based on the fair value of the award. The Company estimates the fair value of stock options and warrants granted using the Black-Scholes-Merton option pricing model and stock grants at their closing reported market value. Stock-based compensation expense for employees amounted to $36,000 and $152,000 for the three months ended September 30, 2026 and 2025, respectively, and $607,000 and $744,000 for the nine months ended September 30, 2026 and 2025, respectively. A stock-based forfeiture adjustment resulted in a reversal of expense amounting to $0 and $125,000 for the three and nine months ended September 30, 2026, respectively, and $0 for the three and nine month periods ended September 30, 2025. Stock-based compensation expense for directors amounted to $14,000 and $14,000 for the three months ended September 30, 2026 and 2025, respectively, and $466,000 and $92,000 for the nine months ended September 30, 2026 and 2025, respectively. Stock compensation expenses for employees and directors were included in operating expenses in the accompanying condensed consolidated statements of operations.

 

11

 

Recently Issued Accounting Pronouncements

 

In November 2024, the FASB issued ASU 2024-03, “Disaggregation of Income Statement Expenses”, which requires public business entities to disclose additional information about specific expense categories in the notes to financial statements at interim and annual reporting periods. The amendments in ASU 2024-03 are effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently assessing the impact that adoption of this new accounting guidance will have on its consolidated financial statements and footnote disclosures.

 

In December 2025, the FASB issued ASU 2025-11, “Interim Reporting (Topic 270): Narrow-Scope Improvements”, which clarifies interim reporting disclosure requirements. The amendments are effective for interim reporting periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of adopting this standard on its consolidated financial statements and related disclosures.

 

The Company does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying condensed consolidated financial statements.

 

Note 3. PROPERTY AND EQUIPMENT

 

The components of property and equipment at September 30, 2026 and December 31, 2025 consisted of the following:

 

    September 30,     December 31,      
    2026     2025      
                 
Land and Improvements   $ 313,000     $ 313,000      
Buildings and Improvements     2,739,000       2,739,000     31.5 years
Machinery and Equipment     26,982,000       26,953,000     5 - 8 years
Tools and Instruments     16,830,000       16,278,000     1.5 - 7 years
Automotive Equipment     266,000       266,000     5 years
Furniture and Fixtures     309,000       309,000     5 - 8 years
Leasehold Improvements     1,188,000       1,139,000     Term of lease
Computers and Software     846,000       705,000     4 - 6  years
Total Property and Equipment     49,473,000       48,702,000      
Less: Accumulated Depreciation     (41,292,000 )     (39,201,000 )    
Property and Equipment, net   $ 8,181,000     $ 9,501,000      

 

Depreciation expense for the three months ended September 30, 2026 and 2025 was approximately $664,000 and $627,000, respectively. Depreciation expense for the nine months ended September 30, 2026 and 2025 was approximately $2,091,000 and $1,814,000, respectively.

 

12

 

Note 4. OPERATING LEASE LIABILITIES

 

The Company leases office and manufacturing facilities under an operating lease that was scheduled to expire on August 31, 2026. During August 2026, the Company and the lessor entered into an Agreement of Modification extending the lease through December 31, 2026 on a month-to-month basis at the then-current lease rate.

 

    Three Months Ended     Nine Months Ended  
    September 30,     September 30,     September 30,     September 30,  
    2026     2025     2026     2025  
Operating lease cost:   $ 248,000     $ 249,000     $ 744,000     $ 810,000  
Total lease cost   $ 248,000     $ 249,000     $ 744,000     $ 810,000  
                                 
Other Information                                
Cash paid for amounts included in the measurement lease liability:     243,000       236,000       730,000       748,000  
Operating cash flow from operating leases   $ 243,000     $ 236,000     $ 730,000     $ 748,000  

 

    September 30,     December 31,  
    2026     2025  
Weighted Average Remaining Lease Term - in years     -       0.75  
Weighted Average discount rate - %     -       9.50 %

 

On October 29, 2026, the Company entered into an Agreement of Modification (“October Agreement”), extending the lease through December 31, 2036. The October Agreement increased the base monthly rent by 3% for the first 60 months of the lease effective January 1, 2027, and then by an additional 3% for the next 60 months. Further, the October Agreement allows for early termination by the tenant on 24 months’ notice to the landlord, at any time after and not before December 31, 2031. Additionally, the landlord is financing on an interest-free basis approximately $757,000 for the replacement of the roof of the facility. This amount is to be repaid by the tenant in the form of additional rent of approximately $6,300 per month for 120 months commencing on January 1, 2027. Should the tenant choose to exercise its option to terminate the lease early, the balance of the amount financed for the roof will be payable upon the Company vacating the premises.

 

Note 5. DEBT

 

Total debt outstanding, excluding Related Party Indebtedness, as of September 30, 2026 is $25,374,000 and was $25,233,000 at December 31, 2025.

 

Indebtedness to third parties consists of the following:

 

    September 30,     December 31,  
    2026     2025  
             
Current Credit Facility - Revolver   $ 18,757,000     $ 17,618,000  
Current Credit Facility - Term Loan     5,069,000       5,855,000  
Solar Credit Facility     943,000       971,000  
Finance lease obligations     605,000       784,000  
Loans Payable - financed assets     -       5,000  
Subtotal     25,374,000       25,233,000  
Less: Current portion     (24,006,000 )     (23,721,000 )
Long-Term Portion   $ 1,368,000     $ 1,512,000  

  

Current Credit Facility

 

The Company has a credit facility (“Current Credit Facility”) with Webster Bank that expires on April 30, 2027. This facility, which was entered into on December 31, 2019, was amended several times and now provides for a $20,000,000 revolving loan (“Revolving Line of Credit”) and a $5,700,000 term loan and a $1,640,000 term loan (“Term Loans”). The loan is secured by a lien on substantially all of the assets of the Company.

 

13

 

As of September 30, 2026, there is $18,757,000 outstanding under the Revolving Line of Credit and $5,069,000 under the Term Loans.

 

As the Current Credit Facility expires on April 30, 2027, the entire Term Loan and all amounts due under the Revolving Line of Credit are classified as short term as of September 30, 2026.

 

The below table shows the timing of payments due under the Term Loan:

 

For the year ending   Amount  
December 31, 2026 (remainder of year)   $ 262,000  
December 31, 2027     4,807,000  
Term Loan payable     5,069,000  
Less: Current portion of Term Loan payable     (5,069,000 )
Total long-term portion of Term Loan payable   $ -  

 

Interest expense related to the Current Credit Facility amounted to approximately $375,000 and $347,000 for the three months ended September 30, 2026 and 2025, respectively, and $1,142,000 and $988,000 for the nine months ended September 30, 2026 and 2025, respectively. Interest expense includes the amortization of deferred finance costs of $0 and $17,000 for the three months ended September 30, 2026 and 2025, respectively, and $1,000 and $51,000 for the nine months ended September 30, 2026 and 2025, respectively.

 

The below summarizes various terms of the Current Credit Facility:

 

● The Company is required to meet a Fixed Charge Coverage Ratio (as defined) that is determined at the end of each fiscal quarter on a rolling twelve month basis of 1.10x. As of September 30, 2026, the Company was in full compliance with this ratio having attained a ratio of 1.30x. At December 31, 2025, the Company was in full compliance with its covenants. The Current Credit Facility limits the amount of capital expenditures and dividends the Company can pay to its stockholders. As of September 30, 2026, the Company was in compliance with this covenant. Substantially all of the Company’s assets are pledged as collateral.

 

  ● For so long as the Term Loan remains outstanding, if Excess Cash Flow (as defined) is a positive number for any fiscal year the Company shall pay an amount equal to the lesser of (i) twenty-five percent (25%) of the Excess Cash Flow for such fiscal year and (ii) the outstanding principal balance of the term loan. Such payment shall be applied to the outstanding principal balance of the Term Loan, on or prior to the April 15 immediately following such fiscal year. For the fiscal year ended December 31, 2025, based on the calculation there was no Excess Cash Flow payment required.

 

  ● Both the Revolving Line of Credit and the Term Loan will bear an interest rate equal to the greater of (i) 3.50% and (ii) a rate per annum equal to the rate per annum published from time to time in the “Money Rates” table of the Wall Street Journal (or such other presentation within The Wall Street Journal as may be adopted hereafter for such information) as the base or prime rate for corporate loans at the nation’s largest commercial bank, less sixty-five hundredths (-0.65%) of one percent per annum. The average interest rate charged was 6.18% and 6.81% for the three months ended September 30, 2026 and 2025, respectively, and 6.11% and 6.81% for the nine months ended September 30, 2026 and 2025, respectively.

 

14

 

The below summarizes certain amendments to the Current Credit Facility 

 

  ● On January 30, 2025, we entered into an Eighth Amendment to provide for an additional Term Loan in the amount of $1,640,000 for the acquisition of equipment. The monthly principal installments on this additional Term Loan are $19,524. This amendment further revised our Financial Covenants. For the rolling twelve-month period ending March 31, 2025 and June 30, 2025, we were required to achieve a Fixed Charge Coverage Ratio of 1.05x. Beginning with the rolling twelve-month period ending September 30, 2025 and going forward the Company is required to achieve a Fixed Charge Coverage Ratio of 1.25x. Additionally, the Company is allowed to pay off up to $4,800,000 of related party notes with funds raised in the Company’s At The Market equity offering. All other covenants remain unchanged. In connection with these changes, the Company paid an amendment fee of $20,000.

 

● On September 10, 2025, the Company entered into a Ninth Amendment where it agreed that $3,930,000 of the proceeds from its ATM Offering would be maintained in an interest-bearing account at Webster Bank. The funds in this account serve as additional security for its obligations under the Current Credit Facility. Additionally, this amendment waived the default as of June 30, 2025.

 

● On December 15, 2025, the Company entered into a Tenth Amendment which waived the defaults caused by the failure to achieve the required fixed charge coverage ratio for the fiscal quarter ended September 30, 2025, and for exceeding the permitted amount of capital expenditures for the fiscal year ending December 31, 2025. The Tenth Amendment also amended the minimum Fixed Charge Coverage Ratio for subsequent periods to 1.10x. Additionally, the maturity dates of the revolving credit and term loans were extended to March 31, 2026, and the capital expenditure covenant was amended. The Company paid an amendment fee of $40,000.

 

● On February 26, 2026, the Company entered into an Eleventh Amendment which extended the maturity date of the revolving credit and term loans to September 30, 2026. The Company paid an amendment fee of $25,000 and agreed to pay an additional fee of $150,000 on the maturity date.

 

● On August 18, 2026, the Company entered into a Twelfth Amendment which extended the maturity date of the revolving credit and term loans to November 30, 2026. The Company paid an amendment fee of $25,000.

 

● On November 9, 2026, the Company entered into a Thirteenth Amendment which extended the maturity date of the revolving credit and term loans to April 30, 2027. The Company paid an amendment fee of $50,000 and agreed to pay an additional fee of $50,000 on the maturity date.

 

Currently, at any time, Webster Bank could choose to exercise additional rights that it has as a result of the Company’s previous defaults under the Current Credit Facility. For example, it could increase the rate of interest or refuse to make loans under the revolving portion of the Current Credit Facility and keep the funds remitted to the collection account. If the lender were to cease making new loans under the revolving facility or limit the amount of loans under the revolving facility, the Company would lack the funds to continue or, possibly, expand operations. To date, the lender has chosen not to exercise any of its remedies, though the Company agreed to put $3,930,000 of ATM proceeds in an interest-bearing account to serve as additional security for the Company’s obligations under the Current Credit Facility.

 

The Company is actively engaged in constructive discussions with various lenders as the Company has been advised by its lender that it will not renew its Current Credit Facility for a period of one or more years. Nevertheless, Webster Bank has agreed to multiple short term extensions of the expiration date of the Current Credit Facility, most recently until April 30, 2027. While these discussions have been professional and remain ongoing, there can be no assurance that agreements will be reached with existing lenders or with alternative financing sources.

 

All amendment fees paid in connection with the Current Credit Facility that are for a future benefit of the Company are included in Deferred Financing Costs, Net, Deposits and Other Assets, in the accompanying consolidated balance sheets and are amortized over the term of the loan.

 

As of September 30, 2026, the Company has borrowing capacity of approximately $1,243,000 under the Revolving Loan.

 

15

 

Solar Credit Facility

 

On August 16, 2023, the Company entered into a financing agreement (“Solar Credit Facility”) with CT Green Bank, a quasi-public agency of the State of Connecticut, for the installation of solar energy systems including replacing the existing roof (“Project”) at its Sterling facility. Advances were made by CT Green Bank upon its approval of costs incurred on the Project up to $934,000. As of October 1, 2024, cumulative advances totaling $934,000 had been made including the payment of CT Green Bank’s closing costs of $25,000. Total interest accrued on the advances at the rate of 5% was $36,000.

 

On October 1, 2024, the total cumulative advances of $934,000 along with the total accrued interest of $36,000 were converted by CT Green Bank, in accordance with the financing agreement, to a 20-year level payment term loan in the amount of $970,000 with interest accruing at the rate of 5.75%. Semi-annual payments in the amount of $42,000 are due commencing on July 1, 2025. The first semi-annual payment was for interest only. The second payment due on January 1, 2026 and all subsequent semi-annual payments include both principal and interest. As of September 30, 2026, the amount classified as short term is $29,000 and the amount classified as long term is $914,000.

 

Interest expense related to the Solar Credit Facility amounted to approximately $14,000 and $14,000 for the three months ended September 30, 2026 and 2025, respectively, and $42,000 and $42,000 for the nine months ended September 30, 2026 and 2025, respectively. 

 

Finance Lease Obligations

 

The Company has entered into finance leases for the purchase of additional manufacturing equipment. The obligations for the finance leases totaled $605,000 and $784,000 as of September 30, 2026 and December 31, 2025, respectively. The leases have an average imputed interest rate of 7.43% per annum and are payable monthly with the final payments due between September of 2026 and May of 2030.

 

    Three Months Ended     Nine Months Ended  
    September 30,     September 30,     September 30,     September 30,  
    2026     2025     2026     2025  
Finance Lease cost:                        
Amortization of ROU assets   $ 49,000     $ 49,000     $ 147,000     $ 147,000  
Interest on lease liabilities     12,000       16,000       39,000       52,000  
Total lease Costs   $ 61,000     $ 65,000     $ 186,000     $ 199,000  
                                 
Other Information:                                
Cash Paid for amounts included in the measurement lease liabilities:                                
Financing cash flow from finance lease obligations   $ 61,000     $ 57,000     $ 179,000     $ 166,000  
                                 
Supplemental disclosure of non-cash activity                                
Acquisition of finance lease asset   $ -     $ -     $ -     $ -  

 

    September 30,     December 31,  
    2026     2025  
             
Weighted Average Remaining Lease Term - in years     3.6       4.8  
Weighted Average Discount rate - %     7.43 %     7.44 %

 

16

 

As of September 30, 2026, the aggregate future minimum finance lease payments, including imputed interest are as follows:

 

For the year ending   Amount  
December 31, 2026 (remainder of year)   $ 48,000  
December 31, 2027     190,000  
December 31, 2028     190,000  
December 31, 2029     191,000  
December 31, 2030     74,000  
Total future minimum finance lease payments     693,000  
Less: imputed interest     (88,000 )
Less: Current portion     (150,000 )
Long-term portion   $ 455,000  

 

Loan Payable – Financed Asset

 

The Company financed the purchase of a delivery vehicle in July 2020. The loan obligation totaled $5,000 as of December 31, 2025. The loan was non-interest bearing and the final payment was due and paid by July 20, 2026.

 

Related Party Indebtedness

 

Taglich Brothers, Inc. is a corporation co-founded by two directors of the Company, Michael and Robert Taglich.

 

Taglich Brothers, Inc. has acted as placement agent for various debt and equity financing transactions and has received cash and equity compensation for their services.

 

From 2016 through 2020, the Company entered into various subordinated notes payable and convertible subordinated notes payable (together referred to as “Related Party Notes”) with Michael and Robert Taglich which generated proceeds to the Company totaling $6,550,000. In connection with the Related Party Notes, Michael and Robert Taglich were issued a total of 35,508 shares of common stock and Taglich Brothers Inc. was issued promissory notes totaling $554,000 for placement agency fees.

 

Under the Eighth Amendment to the Current Credit Facility, the Company was allowed to make principal payments of up to $4,800,000 prior to June 30, 2025, with funds raised in the Company’s At The Market Offering. For the three and nine month periods ended September 30, 2025, the Company paid $1,291,000 of principal payments. Of the $1,291,000 paid, $1,050,000 was paid to Michael Taglich and $241,000 was paid to Taglich Brothers, Inc.

 

The Related Party Notes outstanding as of September 30, 2026 and December 31, 2025 consist of:

 

    Michael Taglich,     Robert Taglich,     Taglich Brothers,        
    Director     Director     Inc.     Total  
Convertible Subordinated Notes   $ 2,416,000     $ 1,905,000     $       -     $ 4,321,000  
Subordinated Notes     -       550,000       -       550,000  
Total   $ 2,416,000     $ 2,455,000     $ -     $ 4,871,000  

 

Of the $4,871,000, approximately $2,519,000 bears an annual rate of interest of 6%, $1,802,000 bears an annual rate of 7% and $550,000 bears an annual interest rate of 12%. Interest expense for the three months ended September 30, 2026 and 2025 on all related party notes payable was $85,000 and $86,000, respectively, and $257,000 and $271,000 for the nine months ended September 30, 2026 and 2025, respectively.

 

17

 

Approximately $2,519,000 of the convertible subordinated notes can be converted at the option of the holder into Common Stock of the Company at $15.00 per share, while the remaining $1,802,000 of the convertible subordinated notes can be converted at the option of the holder into common stock of the Company at $9.30 per share. There are no principal payments due prior to May 1, 2027.

 

The Related Party Notes are subordinate to outstanding debt pursuant to the Current Credit Facility.

 

On November 9, 2026, in connection with the extension of the Current Credit Facility, the Company and the holders of the Related Party Notes agreed to extend the maturity date of the Notes to May 1, 2027. In consideration of the agreement of the holders of the Related Party Notes to the extension, the Company agreed that if the contemplated merger with Tenax Aerospace Acquisition, LLC does not occur on or prior to November 30, 2026, the principal amount of each Related Party Note would be increased by 2%; effective December 1, 2026, the interest rate would be reset at the greater of (x) 12.5% and (y) the Secured Overnight Financing Rate (“SOFR”) plus 8.5%, and if the Company were to default in the payment of any principal or interest payable, the interest rate would increase to the greater of (x) 24% and (y) the SOFR plus 15%. The parties agreed that the conversion prices of the Related Pary Notes would not be changed.

 

Note 6. STOCKHOLDERS’ EQUITY

 

Common Stock – Issuance of Securities

 

The Company issued 5,523 and 4,064 shares of common stock in payment of director fees totaling $14,000 and $14,000 for the three months ended September 30, 2026 and 2025, respectively, and 14,607 and 26,199 shares totaling $42,000 and $92,000 for the nine months ended September 30, 2026 and 2025, respectively.

 

During April of 2026, the Company issued 57,345 shares of common stock upon the vesting of Restricted Stock Units (“RSUs”) to certain employees and withheld the balance of the 94,210 RSUs in satisfaction of tax withholding obligations. This represents a portion of the RSUs granted in 2024.

 

Additionally, during April of 2026, the Company issued 7,775 shares of common stock upon the vesting of RSUs to a former executive pursuant to a separation agreement and withheld the balance of the 12,159 RSUs in satisfaction of withholding tax obligations. This represents a portion of the RSUs granted in February of 2026. (See Note 7. Stock Options and Restricted Stock Units.)

 

Note 7. STOCK OPTIONS AND RESTRICTED STOCK UNITS

 

Stock-Based Compensation

 

Stock Options

 

In September 2025, the shareholders of the Company approved the amendment to the 2022 Equity Incentive Plan (“2022 Plan”) to increase the number of shares authorized to be used under the plan by 250,000 shares, from 650,000 shares to 900,000 shares.

 

The Company recorded stock-based compensation expense for certain employees and members of the Company’s Board of Directors of $0 for the three months ended September 30, 2026 and 2025, respectively, and $35,000 and $22,000 for the nine months ended September 30, 2026 and 2025, respectively, in its condensed consolidated statements of operations, and such amounts were included as a component of operating expenses.

 

18

 

A summary of the status of the Company’s stock options as of September 30, 2026 and December 31, 2025, and changes during the periods then ended are presented below:

 

          Wtd. Avg.  
          Exercise  
    Options     Price  
Balance, January 1, 2025     417,003     $ 7.00  
Granted during the period     60,000       3.00  
Exercised during the period             -  
Terminated/Expired during the period     (51,300 )     10.57  
Balance, December 31, 2025     425,703     $ 6.01  
Granted during the period     -       -  
Exercised during the period     -       -  
Terminated/Expired during the period     (143,250 )     7.45  
Balance, September 30, 2026     282,453     $ 4.79  
                 
Exercisable at September 30, 2026     263,953     $ 4.79  

 

The following table summarizes information about outstanding stock options at September 30, 2026:

 

Range of Exercise Price   Number
Outstanding
    Wtd.Avg,
Life
  Wtd. Avg.
Exercise
Price
 
$3.00 - $23.80     282,453     2.5 Years   $ 4.79  

 

The following table summarizes information about outstanding stock options at December 31, 2025:

 

Range of Exercise Price   Number
Outstanding
    Wtd.Avg,
Life
  Wtd. Avg.
Exercise
Price
 
$3.00 - $23.80     425,703     2.5 Years   $ 6.01  

  

As of September 30, 2026, there was $0 of unrecognized compensation cost related to non-vested stock option awards.

 

The aggregate intrinsic value at September 30, 2026 based on the Company’s closing stock price of $2.55 was $0. The aggregate intrinsic value at December 31, 2025 based on the Company’s closing stock price of $4.07 was approximately $121,000. The aggregate intrinsic value was calculated based on the positive difference between the closing market price of the Company’s Common Stock and the exercise prices of the underlying options.

 

Restricted Stock Units (“RSUs”)

 

During the nine months ended September 30, 2026 and 2025, the Company granted 243,172 and 0 RSUs to certain employees and directors. These RSUs vested immediately.

 

19

 

A summary of the status of the Company’s RSUs as of September 30, 2026 is presented below.

 

    Number of
Units
    Wtd. Avg.
Grant Date
Fair Value
per Unit
 
Unvested units as of January 1, 2025     282,628     $ 6.06  
Granted during the period     3,000       -  
Vested during the period     (95,210 )     6.06  
Forfeited during the period     (2,000 )     -  
Unvested Units as of December 31, 2025     188,418     $ 6.06  
Granted during the period     243,172     $ 3.19  
Vested during the period     (231,013 )     3.19  
Settled     (106,369 )     5.73  
Forfeited during the period     (34,122 )     6.06  
Unvested Units as of September 30, 2026     60,086     $ 6.06  
Vested as of September 30, 2026     231,013     $ 3.19  

 

The Company recorded stock-based compensation expense of $36,000 and $152,000 for the three months ended September 30, 2026 and 2025, respectively, and $870,000 and $722,000 for the nine months ended September 30, 2026 and 2025, respectively, in its condensed consolidated statements of operations, and such amounts were included as a component of operating expenses. Stock-based compensation expense for the nine months ended September 30, 2026 reflects a $125,000 reversal of compensation expense related to a forfeited award.

 

The fair value of the RSUs which were granted in 2024 and vested and settled during the nine months ended September 30, 2026 was $571,000. The fair value of the RSUs which were granted, settled and vested during the nine months ended September 30, 2026 was $39,000. Additionally, the fair value of the RSUs which were granted and vested during the nine months ended September 30, 2026 was $737,000. All of the RSUs vested were net settled such that the Company withheld shares with a value equivalent to the employees’ obligation for the applicable income and other employment taxes, and remitted cash to the appropriate taxing authorities. The total shares withheld were 41,249 and were valued on their vesting date as determined by the Company’s closing stock price. Payments to taxing authorities for tax obligations totaled $131,000.

 

As of September 30, 2026, there was $72,000 of unrecognized compensation cost related to non-vested RSUs, which is to be recognized over the remaining weighted average vesting period of 0.5 years. 

 

Note 8. COMMITMENTS AND CONTINGENCIES

 

On October 2, 2018, Contract Pharmacal Corp. (“Contract Pharmacal”) commenced an action, relating to a Sublease entered into between Air (the Company) and Contract Pharmacal in May 2018.  This sublease involved property that had been occupied by the Company’s subsidiary WMI, the property address was 110 Plant Avenue, Hauppauge, New York.  In the action, Contract Pharmacal sought damages for an amount in excess of $1,000,000 for the Company’s alleged violation of the terms of the subject sublease, this alleged violation specifically involved the failure to make the entire premises available by what Contract Pharmacal claims was the Sublease commencement date. The validity of the action is extremely suspect in that the subject sublease had no specific commencement date and Contract Pharmacal ultimately received all the space covered by the sublease. Court ordered discovery was conducted and following same Contract Pharmacal moved for summary judgment and to amend its complaint to add a new cause of action.  The Company opposed that motion.  On July 8, 2021, the Court denied Contract Pharmacal’s motion for summary judgment and to add an additional cause of action. In the Order, the Court granted Contract Pharmacal’s Motions to drop its claim for specific performance and to amend its Complaint to reduce its claim for damages to $700,000, both of which benefit the Company. Following the Court’s decision, Contract Pharmacal filed a Motion to reargue its original motion which the Company opposed. The Court denied that motion on November 30, 2021. Then on March 10, 2022, Contract Pharmacal filed an appeal of the Court’s decision with the Appellate Division of the State of New York. The Company opposed that appeal. The Company was again successful as the Appellate Division upheld the lower court’s denial of Contract Pharmacal’s motion for summary judgment and its motion to amend its Complaint. Contract Pharmacal has now submitted a motion to the Appellate Division requesting leave to reargue the court’s denial of its original appeal. The Company did oppose that motion. The Appellate Division has yet to act in respect to Contract Pharmacal’s most recent motion to reargue the Court’s denial of the original appeal. The Company continues to dispute the validity of the claims asserted by Contract Pharmacal and intends to contest them vigorously. Even though no decision has ever been rendered by the Appellate Division, the trial court attempted to move the case forward by conducting numerous settlement conferences.  Due to the unreasonable nature of Contract Pharmacal’s demands in light of the strength of their case no settlement occurred.   As a result, the court ordered the matter to proceed.  Since that last court appearance in January of 2026 the action has stalled.  This stall is the direct result of Contract Pharmacal’s refusal to appear for depositions as ordered by the court.

 

20

 

From time to time the Company may be engaged in various lawsuits and legal proceedings in the ordinary course of business. The Company is currently not aware of any legal proceedings, the ultimate outcome of which, in its judgment based on information currently available, would have a material adverse effect on its business, financial condition or operating results. In consultation with legal counsel, there are no proceedings in which any of the Company’s directors, officers or affiliates, or any registered or beneficial stockholder of its common stock, is an adverse party or has a material interest adverse to our interest.

 

Note 9. INCOME TAXES

 

The Company recorded $0 and $0 for income tax expense for the three months ended September 30, 2026 and 2025 respectively, and $18,000 and $0 for the nine months ended September 30, 2026 and 2025, respectively. The amount paid in 2026 is related to state taxes in a specific jurisdiction. In 2025, the estimated annual effective tax rate was zero. In determining the estimated annual effective income tax rate, the Company analyzes various factors, including projections of the Company’s annual earnings and taxing jurisdictions in which the earnings will be generated, the impact of state and local income taxes, the ability to use tax credits and net operating loss carry forwards, and available tax planning alternatives.

 

As of September 30, 2026, and December 31, 2025, the Company provided a full valuation allowance against its net deferred tax assets since the Company believes it is more likely than not that its deferred tax assets will not be realized.

 

Note 10. SEGMENT INFORMATION

 

The Company operates as one operating segment. The Company’s Chief Operating Decision Maker (“CODM”) is its Chief Executive Officer, who reviews financial information presented on a consolidated basis. The CODM used consolidated sales, gross margin and net income (loss) to assess financial performance and allocate resources. These financial metrics are used by the CODM to make key operating decisions, such as the need to allocate its budget to operating expenses and invest in additional equipment. The segment assets are equal to the assets presented in the condensed consolidated balance sheets.

 

The significant expenses that are regularly provided to the CODM are disclosed in the consolidated statements of operations as a part of the condensed consolidated net income (loss). See the condensed consolidated financial statements for all financial information regarding the Company’s operating segment.

 

All revenues of the Company are earned in the United States of America.

 

The Company’s long-lived tangible assets, as well as the Company’s operating lease right-of use assets recognized on the Condensed Consolidated Balance Sheets were located in the United States.

 

Note 11. MERGER INFORMATION

 

On February 16, 2026, the Company and Transitory Air Sub LLC, its wholly owned subsidiary (“Merger Sub”), entered into an Agreement and Plan of Merger (the “Original Merger Agreement”) with Tenax Aerospace Acquisition, LLC, a Delaware limited liability company (“Tenax”), pursuant to which the Company agreed to combine with Tenax and issue shares of the Company’s common stock to the holders of the membership interests of Tenax (the “Tenax Members”) at the closing of the merger based on a calculation of AIR Net Indebtedness (as defined in the Original Merger Agreement). On June 2, 2026, Air Industries Machining Corp. received a payment of $1,971,070 (the “Advance”), from one of its customers for product to be delivered after receipt of the Advance. Subsequently, on June 8, 2026, the Company, Merger Sub and Tenax entered into an amendment (“Amendment No. 1”) to the Original Merger Agreement, which amended the definition of AIR Net Indebtedness (as defined in the Original Merger Agreement) to mitigate the impact of the Advance on the calculation of AIR Net Indebtedness and thereby the number of shares of common stock to be issued pursuant to the Original Merger Agreement.

 

On July 2, 2026, the Company, Merger Sub and Tenax entered into an Amended and Restated Agreement and Plan of Merger (the “A&R Merger Agreement”), which amended and restated the Original Merger Agreement, as amended by Amendment No. 1, in its entirety. Pursuant to the A&R Merger Agreement, Merger Sub will merge with and into Tenax, with Tenax continuing as the surviving company in such merger (the “Merger”) and becoming a wholly-owned subsidiary of the Company.

 

21

 

Pursuant to the terms of the A&R Merger Agreement, the Company will issue 126,900,000 shares of the Company’s common stock (25,380,000 shares after giving effect to a 1 for 5 Reverse Stock Split described herein) (the “Merger Consideration”) to the Tenax Members in connection with the Merger. A portion of the Merger Consideration allocated in respect of membership interests of Tenax underlying certain Tenax warrants that remain unexercised as of the closing, if any, will be reserved by the Company for future issuance upon the exercise of such warrants. The A&R Merger Agreement further provides that the Debt Adjusted AIR Share Price (as defined in the A&R Merger Agreement) shall be $3.05 ($15.25 after giving effect to a 1 for 5 Reverse Stock Split described herein). Each of the Merger Consideration and the Debt Adjusted AIR Share Price is subject to appropriate and equitable adjustment in the event of any subdivision, stock dividend or stock split, combination, recapitalization, exchange or reclassification of the Company’s common stock prior to the closing, including the 1 for 5 Reverse Stock Split described herein. Following the closing, the Tenax Members will collectively own approximately 96% of outstanding Company common stock, and the Company’s stockholders as of immediately prior to the closing will collectively own approximately 4% of outstanding Company common stock.

 

The A&R Merger Agreement requires the Company to amend its articles of incorporation (the “AIR Charter Amendment”) to increase the number of authorized shares of the Company’s common stock from 20 million to 200 million. Subsequent to the effectiveness of the AIR Charter Amendment, the Company shall cause a certificate of change to be filed with the Secretary of State of the State of Nevada effecting a reverse stock split of the issued and outstanding shares of the Company’s common stock at a ratio of one post-split share of the Company’s common stock for every five pre-split shares of the Company’s common stock while simultaneously reducing the number of authorized shares of the Company’s common stock under the Company’s articles of incorporation (after giving effect to the AIR Charter Amendment) by a corresponding factor, with any fractional share of the Company’s common stock otherwise resulting from the split rounded up to the nearest whole share (the “1 for 5 Reverse Stock Split”). Unless the parties agree otherwise, the number of authorized shares of the Company’s common stock immediately after the closing will be 40,000,000. On November 3, 2026, the Company’s Board of Directors approved the 1 for 5 Reverse Stock Split. Subject to stockholder approval of the AIR Charter Amendment at the special meeting of stockholders to be held on November 18, 2026 and the effectiveness of the AIR Charter Amendment, the 1 for 5 Reverse Stock Split is expected to become effective on November 20, 2026.

 

The A&R Merger Agreement eliminates the post-closing tender offer contemplated by the Original Merger Agreement, under which the Company would have been required, within five business days following the closing, to commence a tender offer to purchase up to 1,000,000 shares of the Company’s common stock at a purchase price equal to the Debt Adjusted AIR Share Price (as defined in the Original Merger Agreement) if the volume weighted average price of the Company’s common stock during the 20 trading days preceding the closing was less than the Debt Adjusted AIR Share Price.

 

The A&R Merger Agreement further requires that, promptly following the date of the A&R Merger Agreement, the Company file with the SEC a Registration Statement on Form S-4, which will register the shares of the Company’s common stock to be issued to the Tenax Members pursuant to the A&R Merger Agreement, and will include a proxy statement/prospectus relating to the Merger, and the matters to be voted on by the Company stockholders. Each of the Company and Tenax shall use its reasonable best efforts to cause the Registration Statement to become effective under the Securities Act as promptly as practicable and to keep the Registration Statement effective for so long as necessary to consummate the Merger. Such Registration Statement was filed on July 22, 2026, with subsequent amendments on October 2, 2026 and October 22, 2026. The registration statement became effective on November 4, 2026.

 

On July 31, 2026, the Company, Merger Sub and Tenax entered into an amendment to the A&R Merger Agreement which extended the Outside Date (as defined in the A&R Merger Agreement) to close the transaction from September 30, 2026 to November 30, 2026.

 

On November 7, 2026, the Company received a letter from Tenax stating that the entry by the Company into the amendments to the Current Credit Facility and the Related Party Notes described in Note 5 without Tenax’s prior written consent would constitute a breach of the A&R Merger Agreement. In the letter, Tenax stated that it does not consent to the amendment of the Related Party Notes, that its review of the amendment to the Current Credit Facility is ongoing and that it has not provided its consent thereto, and that it reserves all of its rights under the A&R Merger Agreement.

 

The Company denies the claims made by Tenax and notes that the fee paid in connection with the amendment to the Current Credit Facility is not material and is within the ordinary course of business and that it would have been a breach of the duties of the Company’s directors and officers to allow the Current Credit Facility to expire in the event that the contemplated merger with Tenax was not consummated prior to the November 30, 2026, maturity date. The Company further notes that the holders of the Related Party Notes will not receive any consideration for their agreement to extend the maturity date of their notes if the contemplated merger closes by November 30, 2026, at which time these notes will be repaid.

 

The closing of the Merger is subject to risks and uncertainties and certain specified conditions, including, among other things: (a) the expiration or termination of the applicable waiting period under the Hart-Scott-Rodino Act, (b) the listing of the Merger Consideration on the NYSE American, and (c) other customary conditions for a transaction such as the Merger, such as the absence of any legal restraint prohibiting the consummation of the Merger and there not having occurred with respect to the Company or Tenax’s business a material adverse event, subject to certain customary exceptions.

 

Tenax is a leading provider of special mission aviation solutions that combine aircraft sourcing, financing and modification with aviation services including pilots, maintenance and other types of program support. Additionally, Tenax has a long-standing relationship with key government customers.

 

 

22

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion of our financial condition and results of operations should be read in conjunction with the unaudited condensed consolidated financial statements and notes to those statements included elsewhere in this Form 10-Q and with the audited consolidated financial statements and the notes thereto included in our Annual Report on Form 10-K, for the year ended December 31, 2025 (the “2025 Form 10-K”). This discussion contains forward-looking statements that involve risks and uncertainties. You should specifically consider the various risk factors identified in this report and our 2025 Form 10-K and the Registration Statement on Form S-4 filed with the SEC on July 22, 2026, and Amendments to Form S-4 filed with the SEC on October 2, 2026 and October 22, 2026 that could cause actual results to differ materially from those anticipated in these forward-looking statements.

 

Business Overview

 

We believe we are one of the leading manufacturers of precision components and assemblies for large aerospace and defense contractors. Our rich history dates to 1941, producing parts for World War II fighter aircraft. Since then, we have maintained an impeccable record with no known incidents of part failure leading to a fatal mission. We became a public company in 2005.

 

Our products include landing gear, flight controls, engine mounts and components for aircraft jet engines and ground turbines and other complex machines. The ultimate end-user for most of our products is the U.S. government, foreign governments, and commercial global airlines. Whether it is a small individual component for assembly by others or complete assemblies we manufacture ourselves, our high quality and extremely reliable products are used in mission critical operations that are essential for safety of military personnel and civilians.

 

Although our net sales are concentrated amongst a number of defense and aerospace prime contractors, we have cultivated long-standing relationships with a number of their subsidiaries and/or business units. Additionally, our net sales are generated across several high-profile platforms and programs including: the F-18 Hornet, the E-2 Hawkeye, the UH-60 Black Hawk Helicopters, Geared Turbo-Fan (“GTF”) Engines (used on smaller aircraft such as the Airbus A220 and Embraer E2), the CH-53 Helicopter, the F-35 Lightning II and the F-15 Eagle Tactical Fighter. In many cases, we are the sole or single supplier of certain parts and components and receive LTAs from our customers, both demonstrating their commitment to us.

 

Winning a new contract award is highly competitive. Our ability to win new contract awards generally requires us to deliver superior quality products, more quickly and with lower pricing than our competitors. Accordingly, we must continually invest in process improvements and capital equipment. Recent investments in new equipment have improved the productive capacity of our employees, increased our efficiency and speed, and expanded the size of products we can manufacture. We strategically operate two state-of-the-art manufacturing centers in the U.S. This allows for rigorous oversight of production and the adherence to stringent quality standards. Although there is currently a shortage of skilled workers, we maintain a highly trained and close-knit team of over 150 professionals committed to driving excellence and precision in every aspect of our operations.

 

Our period-to-period net sales and operating results are significantly impacted by timing. In addition, our gross profit is affected by a variety of factors, including the mix and complexity of products, production efficiencies, price competition and general business operating environments. In some cases, our gross profit is impacted by our ability to deliver replacement parts on short notice. Our operations have a large percentage of fixed factory overhead. As a result, our profit margins are highly variable with sales volumes.

 

For the past several years, despite facing significant financial and operational challenges, we have strategically invested substantial amounts in new capital equipment, tooling, and processes to bolster our competitive position. Additionally, we expanded our sales and marketing efforts, with a sharp focus on expanding relationships with existing customers and cultivating new ones. Looking ahead to the remainder of 2026, we are focused on securing new contract awards and improving operations and profitability.

 

As of September 30, 2026, we have total unfilled contract values amounting to $280.7 million (including our $141.4 million in backlog and all potential orders against LTA agreements previously awarded to us).

 

23

 

Recent Developments

 

Extension of Maturity of Indebtedness

 

On November 9, 2026, we entered into the Thirteenth Amendment to the Current Credit Facility which extended the maturity date of the Current Credit Facility to April 30, 2027. Concurrently, we entered into an amendment to the Related Party Notes which extended the maturity of the Notes to May 1, 2027.

 

Merger Agreement

 

On February 16, 2026, we and Transitory Air Sub LLC, our wholly owned subsidiary (“Merger Sub”), entered into an Agreement and Plan of Merger (the “Original Merger Agreement”) with Tenax Aerospace Acquisition, LLC, a Delaware limited liability company (“Tenax”), pursuant to which we agreed to combine with Tenax and issue shares of our common stock to the holders of the membership interests of Tenax (the “Tenax Members”) at the closing of the merger based on a calculation of AIR Net Indebtedness (as defined in the Original Merger Agreement). On June 2, 2026, our subsidiary, Air Industries Machining Corp., received a payment of $1,971,070, (the “Advance”), from one of its customers for product to be delivered after receipt of the Advance. Subsequently, on June 8, 2026, we, Merger Sub and Tenax entered into an amendment (“Amendment No. 1”) to the Original Merger Agreement which amended the definition of AIR Net Indebtedness (as defined in the Original Merger Agreement) to mitigate the impact of the Advance on the calculation of AIR Net Indebtedness and thereby the number of shares of common stock to be issued pursuant to the Original Merger Agreement.

 

On July 2, 2026, we, Merger Sub and Tenax entered into an Amended and Restated Agreement and Plan of Merger (the “A&R Merger Agreement”), which amended and restated the Original Merger Agreement, as amended by Amendment No. 1, in its entirety. Pursuant to the A&R Merger Agreement, Merger Sub will merge with and into Tenax, with Tenax continuing as the surviving company in such merger (the “Merger”) and becoming our wholly owned subsidiary.

 

Pursuant to the A&R Merger Agreement, the number of shares of common stock we will issue has been fixed at 126,900,000 shares (25,380,000 shares after giving effect to a 1 for 5 Reverse Stock Split described herein) (the “Merger Consideration”) for the Tenax Members in connection with the Merger. A portion of the Merger Consideration allocated in respect of membership interests of Tenax underlying certain Tenax warrants that remain unexercised as of the closing, if any, will be reserved by us for future issuance upon the exercise of such warrants. The A&R Merger Agreement further provides that the Debt Adjusted AIR Share Price (as defined in the A&R Merger Agreement) shall be $3.05 ($15.25 after giving effect to a 1 for 5 Reverse Stock Split described herein). Each of the Merger Consideration and the Debt Adjusted AIR Share Price is subject to appropriate and equitable adjustment in the event of any subdivision, stock dividend or stock split, combination, recapitalization, exchange or reclassification of our common stock prior to the closing, including the 1 for 5 Reverse Stock Split described herein. On November 3, 2026, our Board of Directors approved the 1 for 5 Reverse Stock Split to become effective on November 20, 2026.

 

The A&R Merger Agreement requires us to amend our articles of incorporation (the “AIR Charter Amendment”) to increase the number of authorized shares of our common stock from 20 million to 200 million. Subsequent to the effectiveness of the AIR Charter Amendment, we shall cause a certificate of change to be filed with the Secretary of State of the State of Nevada effecting a reverse stock split of the issued and outstanding shares of our common stock at a ratio of one post-split share of our common stock for every five pre-split shares of our common stock while simultaneously reducing the number of authorized shares of our common stock under our articles of incorporation (after giving effect to the AIR Charter Amendment) by a corresponding factor, with any fractional share of our common stock otherwise resulting from the split rounded up to the nearest whole share (the “1 for 5 Reverse Stock Split”). Unless the parties agree otherwise, the number of authorized shares of our common stock immediately after the closing will be 40,000,000.

 

The A&R Merger Agreement eliminates the post-closing tender offer contemplated by the Original Merger Agreement, under which we would have been required, within five business days following the closing, to commence a tender offer to purchase up to 1,000,000 shares of our common stock at a purchase price equal to the Debt Adjusted AIR Share Price (as defined in the Original Merger Agreement) if the volume weighted average price of our common stock during the 20 trading days preceding the closing was less than the Debt Adjusted AIR Share Price.

 

24

 

The A&R Merger Agreement further requires that, promptly following the date of the A&R Merger Agreement, we file with the SEC a Registration Statement on Form S-4, which will register the shares of our common stock to be issued to the Tenax Members pursuant to the A&R Merger Agreement, and will include a proxy statement/prospectus relating to the Merger, and the matters to be voted on by our stockholders. We and Tenax have agreed to use reasonable best efforts to cause the Registration Statement to become effective under the Securities Act as promptly as practicable and to keep the Registration Statement effective for so long as necessary to consummate the Merger. Such Registration Statement was filed on July 22, 2026, with subsequent amendments on October 2, 2026 and October 22, 2026. The registration statement became effective on November 4, 2026.

 

On July 31, 2026, we, Merger Sub and Tenax entered into an amendment (the “Amendment”) to the A&R Merger Agreement, which extended the Outside Date (as defined in the A&R Merger Agreement) to close the transaction from September 30, 2026 to November 30, 2026.

 

The closing of the Merger pursuant to the A&R Merger Agreement is subject to risks and uncertainties and certain specified conditions, including, among other things: (a) the expiration or termination of the applicable waiting period under the Hart-Scott-Rodino Act, (b) the listing of the Merger Consideration on the NYSE American, and (c) other customary conditions for a transaction such as the Merger, such as the absence of any legal restraint prohibiting the consummation of the Merger and there not having occurred with respect to the Company or Tenax’s business a material adverse event, subject to certain customary exceptions.

 

For a more complete description of the A&R Merger Agreement as amended by the Amendment, transactions to be consummated, actions to be taken and agreements entered into or to be entered into in connection therewith, reference is made to the Current Reports on Form 8-K filed July 9, 2026, and August 3, 2026 and the full text of the A&R Merger Agreement, the Amendment and the documents that are exhibits thereto.

 

On November 7, 2026, we received a letter from Tenax stating that the entry by the Company into the amendments to the Current Credit Facility and the Related Party Notes described below without Tenax’s prior written consent would constitute a breach of the A&R Merger Agreement. In the letter, Tenax stated that it does not consent to the amendment of the Related Party Notes, that its review of the amendment to the Current Credit Facility is ongoing and that it has not provided its consent thereto, and that it reserves all of its rights under the A&R Merger Agreement.

 

We deny the claims made by Tenax and note that the fee paid in connection with the amendment to the Current Credit Facility is not material and is within the ordinary course of business and that it would have been a breach of the duties of our directors and officers to allow the Current Credit Facility to expire in the event that the contemplated merger with Tenax was not consummated prior to the November 30, 2026, maturity date. We further note that the holders of the Related Party Notes will not receive any consideration for their agreement to extend the maturity date of their notes if the contemplated merger closes by November 30, 2026, at which time these notes will be repaid.

 

Except where specifically noted, the discussion of our business, operations, management team and financial results contained herein gives no effect to changes that would occur as a result of or subsequent to the consummation of the Merger.

 

Tenax is a leading provider of special mission aviation solutions that combine aircraft sourcing, financing and modification with aviation services including pilots, maintenance and other types of program support. Additionally, Tenax has a long-standing relationship with key government customers.

 

RESULTS OF OPERATIONS

 

Selected Financial Information:

 

    Three Months
Ending
September 30,
2026
    2026 Percentage of
Net Sales
    Three Months Ending
September 30,
2025
    2025 Percentage of
Net Sales
    Change
2026 vs
2025
    Percent
Change
2026 vs
2025
 
                                     
Net sales   $ 14,551,000       100.0 %   $ 10,309,000       100.0 %   $ 4,242,000       41.15 %
Cost of sales     10,846,000       74.5 %     8,014,000       77.7 %     2,832,000       35.34 %
Gross profit     3,705,000       25.5 %     2,295,000       22.3 %     1,410,000       61.44 %
Operating expenses     2,406,000       16.5 %     1,979,000       19.2 %     427,000       21.58 %
Interest expense     486,000       3.3 %     466,000       4.5 %     20,000       4.29 %
Other income, net     133,000       0.9 %     106,000       1.0 %     27,000       25.47 %
Provision for income taxes     -       0.0 %     -       0.0 %     -       -  
Net income (loss)   $ 946,000       6.5 %   $ (44,000 )     -0.4 %   $ 990,000       2250.00 %

 

25

 

    Nine Months Ending
September 30,
2026
    2026 Percentage of
Net Sales
    Nine Months Ending
September 30,
2025
    2025 Percentage of
Net Sales
    Change
2026 vs
2025
    Percent
Change
2026 vs
2025
 
                                     
Net sales   $ 38,152,000       100.0 %   $ 35,111,000       100.0 %   $ 3,041,000       8.66 %
Cost of sales     29,362,000       77.0 %     28,754,000       81.9 %     608,000       2.11 %
Gross profit     8,790,000       23.0 %     6,357,000       18.1 %     2,433,000       38.27 %
Operating expenses     8,422,000       22.1 %     6,779,000       19.3 %     1,643,000       24.24 %
Interest expense     1,482,000       3.9 %     1,354,000       3.9 %     128,000       9.45 %
Other income, net     212,000       0.6 %     322,000       0.9 %     (110,000 )     -34.16 %
Provision for income taxes     18,000       0.0 %     -       0.0 %     18,000       -  
Net loss   $ (920,000 )     -2.4 %   $ (1,454,000 )     -4.1 %   $ 534,000       36.73 %

 

Balance Sheet Data:

 

    September 30,
2026
    December 31,
2025
    Change     Percent Change  
                         
Cash   $ 702,000     $ 680,000     $ 22,000       3.24 %
Working capital   $ 7,027,000     $ 5,238,000     $ 1,789,000       34.15 %
Total assets   $ 58,159,000     $ 58,329,000     $ (170,000 )     -0.29 %
Total stockholders' equity   $ 19,098,000     $ 19,201,000     $ (103,000 )     -0.54 %

 

Results of Operations for the three months ended September 30, 2026

 

Net Sales: Net sales for the three months ended September 30, 2026 were $14,551,000, an increase of $4,242,000, or 41.1%, compared with $10,309,000 that we achieved in the three months ended September 30, 2025. The period-over-period increase in net sales was primarily due to overall changes in the mix of products delivered in response to customer orders.

 

The composition of customers that exceeded 10% of our net sales for the three months ended September 30, 2026 and 2025 are shown below:

 

    Percentage of Net Sales  
Customer   2026     2025  
RTX (a)     29.3 %     38.2 %
Transaero     22.5 %     -  
Lockheed Martin     14.6 %     30.2 %

 

(a) RTX includes Collins Landing Systems and Collins Aerostructures

 

26

 

The composition of our net sales by platform or program profiles for the three months ended September 30, 2026 and 2025 are shown below:

 

    Percentage of Net Sales  
Platform or Program   2026     2025  
UH-60 Black Hawk Helicopter     30.9 %     20.9 %
Geared Turbo Fan Engine     26.5 %     33.4 %
CH-53 Helicopter     9.5 %     10.5 %
F-35 Lightning II     5.2 %     5.9 %
E-2D Hawkeye     3.2 %     4.1 %
F-18 Hornet     0.0 %     1.0 %
All other platforms     24.7 %     24.2 %
Total     100.0 %     100.0 %

 

Period-to-period changes in customer mix and related platforms and programs are largely attributable to customer requirements, availability of parts, production capacity and timing.

 

Gross Profit: Gross profit for the three months ended September 30, 2026, was $3,705,000 as compared to $2,295,000 for the three months ended September 30, 2025. Our gross profit percentage for the three months ended September 30, 2026 increased to 25.5% from 22.3% for the three months ended September 30, 2025. The increase in margin was attributed to changes in the sales across our major platforms, shifts in product mix, and overall operating efficiencies.

 

Operating Expenses: Operating expenses were $2,406,000, for the three months ended September 30, 2026, an increase of $427,000, from $1,979,000 for the three months ended September 30, 2025. As a percentage of consolidated net sales, operating expenses decreased to 16.5%, compared to the 19.2% achieved during the three months ended September 30, 2025. The dollar increase was primarily driven by professional expenses associated with our pending merger, as well as costs associated with the continued improvement of our information technology system and hardening our cyber-security defenses, offset by decreases in stock-based compensation costs. We continue to look for ways to reduce our costs and improve our operating performance and financial results.

 

Interest Expense: Interest expense was $486,000 during the three months ended September 30, 2026, an increase of $20,000 or 4.3% from $466,000 during the three months ended September 30, 2025. The increase is primarily attributable to higher borrowing levels during a portion of the period partially offset by a decrease in the average interest rate on outstanding debt pursuant to our Current Credit Facility which decreased to 6.18% in 2026 as compared to 6.81% in 2025.

 

Net Income (Loss): Net income for the three months ended September 30, 2026 was $946,000, compared to a net loss of $44,000 for the three months ended September 30, 2025, for the reasons discussed above.

 

Results of Operations for the nine months ended September 30, 2026

 

Net Sales: Net sales for the nine months ended September 30, 2026 were $38,152,000, an increase of $3,041,000, or 8.7%, compared with $35,111,000 that we achieved in the nine months ended September 30, 2025. The period-over-period increase in net sales was primarily due to overall changes in the mix of products delivered in response to customer orders.

 

27

 

The composition of customers that exceeded 10% of our net sales for the nine months ended September 30, 2026 and 2025 are shown below:

 

    Percentage of Net Sales  
Customer   2026     2025  
RTX (a)     27.8 %     37.1 %
Lockheed Martin     24.9 %     32.5 %

 

(a) RTX includes Collins Landing Systems and Collins Aerostructures

 

The composition of our net sales by platform or program profiles for the nine months ended September 30, 2026 and 2025 are shown below:

 

    Percentage of Net Sales  
Platform or Program   2026     2025  
UH-60 Black Hawk Helicopter     29.9 %     20.9 %
Geared Turbo Fan Engine     24.3 %     31.7 %
CH-53 Helicopter     8.6 %     12.6 %
E-2D Hawkeye     7.0 %     8.5 %
F-35 Lightning II     6.5 %     4.8 %
F-18 Hornet     0.8 %     1.4 %
All other platforms     22.9 %     20.1 %
Total     100.0 %     100.0 %

 

Gross Profit: Gross profit for the nine months ended September 30, 2026, was $8,790,000 as compared to $6,357,000 for the nine months ended September 30, 2025. Our gross profit percentage for the nine months ended September 30, 2026 increased to 23.0% from 18.1% for the nine months ended September 30, 2025. The increase in margin was attributed to changes in the sales across our major platforms, shifts in product mix and overall operating efficiencies.

 

Operating Expenses: Operating expenses were $8,422,000, for the nine months ended September 30, 2026, an increase of $1,643,000, from $6,779,000 for the nine months ended September 30, 2025. As a percentage of consolidated net sales, operating expenses increased to 22.1%, compared to 19.3% incurred during the nine months ended September 30, 2025. The dollar increase was primarily driven by professional expenses associated with our pending merger and increases in stock compensation expense, and costs associated with the continued improvement of our information technology system and hardening our cyber-security defenses. We continue to look for ways to reduce our costs and improve our operating performance and financial results.

 

Interest Expense: Interest expense was $1,482,000 during the nine months ended September 30, 2026, an increase of $128,000 or 9.5% from $1,354,000 during the nine months ended September 30, 2025. The increase is primarily attributable to higher borrowing levels during a portion of the period partially offset by a reduction in the average interest rate on outstanding debt pursuant to our Current Credit Facility which decreased to 6.11% in 2026 as compared to 6.81% in 2025.

 

Net Loss: Net Loss for the nine months ended September 30, 2026 was $920,000, compared to a net loss of $1,454,000 for the nine months ended September 30, 2025, for the reasons discussed above.

 

28

 

LIQUIDITY AND CAPITAL RESOURCES 

  

As of September 30, 2026, we have debt service requirements related to:

 

1) Outstanding indebtedness under our Current Credit Facility of $23,826,000 (consisting of a Revolving Loan of $18,757,000 and a Term Loan of $5,069,000). This debt matures on April 30, 2027, and we are required to make monthly payments on the Term Loan of approximately $87,000 until the loan matures.

 

2) Related Party Notes of approximately $4,871,000, maturing on May 1, 2027.

 

3) Various equipment leases and contractual obligations related to our business, including advances under our Solar Facility for the installation of solar energy systems including the replacement of the existing roof at our Sterling Facility.

 

Under the terms of the Current Credit Facility, as amended, we are required to meet a prescribed Fixed Charge Coverage Ratio (as defined) that is determined at the end of each fiscal quarter on a rolling twelve-month basis. This ratio is a financial metric that we use to measure our ability to cover fixed charges such as interest and lease expenses as divided by EBITDA (as defined in the Current Credit Facility) which represents net income (loss) before interest, taxes, depreciation and amortization. As of September 30, 2026, the Company is required to meet a Fixed Charge Coverage Ratio on a rolling twelve-month basis of 1.10x. As of September 30, 2026, we were in compliance with this ratio having attained a ratio of 1.30x. Additionally, we are in compliance with all other required business and financial covenants in the Current Credit Facility.

 

The Current Credit Facility and Related Party Notes are due on April 30, 2027 and May 1, 2027, respectively and are classified as current liabilities on the condensed consolidated balance sheet as of September 30, 2026. As a result of the due dates of this debt, there is substantial doubt about our ability to continue as a going concern for the twelve months following the date of filing of these consolidated financial statements. Webster Bank has advised us that it does not want to renew our Current Credit Facility for a period of one or more years. Nevertheless, it has agreed to multiple short term extensions of the Current Credit Facility, most recently until April 30, 2027. In addition to discussions with our lenders, we are seeking to merge with Tenax pursuant to the terms of the A&R Merger Agreement, as amended.

 

On November 9, 2026, in connection with the extension of the Current Credit Facility, we and the holders of the Related Party Notes agreed to extend the maturity date of the Notes to May 1, 2027. In consideration of the agreement of the holders of the Related Party Notes to the extension, we agreed that if the contemplated Merger with Tenax does not occur on or prior to November 30, 2026, the principal amount of each Related Party Note would be increased by 2%; effective December 1, 2026, the interest rate would be reset at the greater of (x) 12.5% and (y) the Secured Overnight Financing Rate (“SOFR”) plus 8.5%, and if we were to default in the payment of any principal or interest payable, the interest rate would increase to the greater of (x) 24% and (y) the SOFR plus 15%. The parties agreed that the conversion prices of the convertible Related Party Notes would not be changed.

 

Pursuant to the Current Credit Facility we are required to maintain a collection account with our lender into which substantially all cash receipts are remitted. Should our lender choose to increase the rate of interest or refuse to make loans under the revolving portion of the Current Credit Facility and keep the funds remitted to the collection account, it would adversely impact our operating results. If the lender were to cease making new loans under the revolving facility, we would lack the funds to continue operations. The Current Credit Facility expiration date and the rights granted to the lender, combined with the reasonable possibility that we might fail to meet covenants in the future, raise substantial doubt about our ability to continue as a going concern for the one year commencing as of the date of filing this report. To date, the lender has chosen not to exercise any of its remedies, though we have agreed to place $3,930,000 of ATM proceeds in an interest-bearing account with the lender to serve as additional security for our obligations under the Current Credit Facility and agreed to pay $50,000 for its most recent agreement to extend the maturity date to April 30, 2027. It is likely that the lender under our Current Credit Facility and the holders of our Related Party Notes will require additional fees for their respective agreement to extend the maturity date of the Current Credit Facility beyond April 30, 2027 and the Related Party Notes beyond May 1, 2027.

 

29

 

To support current operations and strategic initiatives, beginning in December 2024 we raised capital through public market sales of our common stock and believe we can continue to access equity markets in future periods, though there is no assurance as to our ability to do so or as to the price and terms under which we could issue equity securities. During the year ended December 31, 2025, we sold 1,213,593 shares of common stock in the public market and generated gross proceeds of $4,869,000, of which approximately $3,930,000 is restricted for the benefit of the Current Credit Facility lender. Since initiating the sales in December 2024, we have sold a total of 1,330,444 shares for gross proceeds of $5,375,000. In light of ongoing negotiations with our lenders and in accordance with the A&R Merger Agreement with Tenax, we have temporarily paused all equity raising activity.

 

The following is a brief discussion of the recent amendments to the Current Credit Facility (all of which have been included as exhibits to reports filed with the SEC):

 

  ● On January 30, 2025, we entered into an Eighth Amendment to provide for an additional Term Loan in the amount of $1,640,000 for the acquisition of equipment. The monthly principal installments on this additional Term Loan are $19,524. This amendment further revised our Financial Covenants. For the rolling twelve-month period ending March 31, 2025 and June 30, 2025, we were required to achieve a Fixed Charge Coverage Ratio of 1.05x. Beginning with the rolling twelve-month period ending September 30, 2025 and going forward the Company is required to achieve a Fixed Charge Coverage Ratio of 1.25x. All other covenants remain unchanged. In connection with these changes, we paid an amendment fee of $20,000.

 

  ● On September 10, 2025, we entered into a Ninth Amendment where we agreed that $3,930,000 of the proceeds from our ATM Offering would be maintained in an interest-bearing account. The funds in this account serve as security for our obligations under the Current Credit Facility.

 

● On December 15, 2025, we entered into a Tenth Amendment which waived the defaults caused by the failure to achieve the required fixed charge coverage ratio for the fiscal quarter ended September 30, 2025, and for exceeding the permitted amount of capital expenditures for the fiscal year ending December 31, 2025. The Tenth Amendment also amended the minimum Fixed Charge Coverage Ratio required for subsequent periods to 1.10x. Additionally, the maturity dates of the revolving credit and term loans were extended to March 31, 2026, and the capital expenditure covenant was amended. We paid an amendment fee of $40,000.

 

● On February 26, 2026, we entered into an Eleventh Amendment which extended the maturity date of the revolving credit and term loans to September 30, 2026. We paid an amendment fee of $25,000 and agreed to pay an additional fee of $150,000 on the maturity date of the Current Credit Facility.

 

● On August 18, 2026, we entered into a Twelfth Amendment which extended the maturity date of the revolving credit and term loans to November 30, 2026. We paid an amendment fee of $25,000.

 

● On November 9, 2026, we entered into a Thirteenth Amendment which extended the maturity date of the revolving credit and term loans to April 30, 2027. We paid an amendment fee of $50,000 and agreed to pay an additional fee of $50,000 on the maturity date of the Current Credit Facility.

 

30

 

As of September 30, 2026, we have borrowing capacity of approximately $1,243,000 under the Revolving Loan.

 

In addition to required Term Loan payments we may have to make additional payments under the Current Credit Facility. For so long as the Term Loan under the Current Credit Facility remains outstanding, if Excess Cash Flow (as defined) is a positive amount for any fiscal year, we are obligated to pay an amount equal to the lesser of (i) twenty-five percent (25%) of the Excess Cash Flow and (ii) the outstanding principal balance of the Term Loan. Such payment shall be applied to the outstanding principal balance of the Term loan, on or prior to the April 15 immediately following such fiscal year. For the fiscal year ended December 31, 2025, based on the calculation there is no Excess Cash Flow payment required.

 

In addition to the outstanding indebtedness under the Current Credit Facility and Related Party Notes, we have various equipment leases and contractual obligations of an ongoing nature which we service in the ordinary course out of our cash flow from operations.

 

Our material cash requirements are for debt service, funding working capital and capital expenditures. We have historically met these requirements with funds provided by a combination of cash generated from operating activities and cash generated from equity and debt financing transactions. Based on our current revenue visibility, strength of our backlog, and availability under our Current Credit Facility, we believe that we have sufficient liquidity to meet our day-to-day cash requirements for our operations. However, we must pay or refinance large portions of our indebtedness prior to April 30, 2027 and, even if the lender under our Current Credit Facility were to agree to additional extensions, the extensions are likely to be short term and require the payment of significant fees. Further, as a condition to any extension which might be agreed to by our current lender or a refinancing of our Current Credit Facility, our current lender or a new lender may require that the holders of our Related Party Notes extend or otherwise modify the subordination agreements they have given in favor of our current lender and the holders of the Related Party Notes may seek consideration for agreeing to do so.

 

We have engaged in discussions with Webster Bank and the holders of our Related Party Notes to explore potential extensions or refinancings of our obligations. Webster Bank has advised us that it will not extend our Current Credit Facility indefinitely and may require us to make significant payments in consideration of its agreement to extend the Current Credit Facility beyond April 30, 2027. Refinancing our indebtedness may require us to pay higher interest rates than we currently pay, agree to more restrictive business or financial covenants or involve the issuance of debt, equity and/or new securities convertible into or exercisable or exchangeable for our common stock to our lenders or to third parties to reduce the amount of our debt. Any failure to refinance our existing debt or obtain additional working capital when required would have a material adverse effect on our business and financial condition. Any issuances of our common stock, preferred stock, or securities such as warrants or notes that are convertible into, exercisable or exchangeable for, our capital stock, would have a dilutive effect on the voting and economic interest of our existing stockholders.

 

Cash Flow

 

The following table summarizes our net cash flow from operating, investing and financing activities for the periods indicated below (in thousands):

 

    Nine Months Ended  
    September 30,  
    2026     2025  
             
Cash provided by (used in)            
Operating activities   $ 783     $ (754 )
Investing activities     (771 )     (2,818 )
Financing activities     10       6,875  
Net increase in cash   $ 22     $ 3,303  

 

31

 

Cash Provided by Operating Activities

 

For the nine months ended September 30, 2026, net cash provided by operating activities was $783,000, compared to net cash used in operations of $754,000 for the nine months ended September 30, 2025. The increase reflects the improvement year over year in our operating performance and was primarily attributable to a $1,529,000 net increase in customer deposits received on certain contracts and a lower increase in inventory compared with the prior-year period. Inventory increased $1,946,000, reflecting purchases of raw material and work-in-process inventory to support production requirements associated with our funded backlog and anticipated deliveries. The sources of cash were partially offset by a $1,007,000 decrease in accounts payable and accrued expenses due primarily to the timing of vendor payments, a $702,000 decrease in operating lease liabilities, and a $277,000 increase in accounts receivable.

 

For the nine months ended September 30, 2025, net cash used in operating activities of $754,000 was primarily attributable to a $5,616,000 increase in inventory and a $673,000 decrease in customer deposits, partially offset by a $2,135,000 decrease in accounts receivable resulting from customer collections and a $2,043,000 increase in accounts payable and accrued expenses resulting from the timing of vendor payments.

 

Operating cash flows can fluctuate from period to period due to customer billing and collection cycles, inventory purchases required to support production activity, customer advance payments and the timing of vendor payments. During the nine months ended September 30, 2026, the Company experienced increasing inventory levels as it invests in raw materials and work-in-process inventory to support production requirements associated with its funded backlog. Management expects inventory levels and related working capital requirements to remain elevated as backlog is executed and production activity increases. Customer deposits have also become a significant source of working capital; however, the timing and amount of future deposits may vary based on contract awards and production schedules. In addition, the Company’s liquidity is affected by the April 30, 2027 maturity of its credit facility and the May 1, 2027 maturity of its subordinated notes. The Company is pursuing extensions and refinancing alternatives to address these obligations.

 

Cash Used in Investing Activities

 

During the nine months ended September 30, 2026, we continued to make investments to enhance our competitiveness and market position. Cash used in investing activities of $771,000 and $2,818,000, during the nine months ended September 30, 2026 and 2025, respectively, was for new machinery and equipment, net of proceeds of $200,000 in 2025 for the sale of equipment.

 

The investments made in 2026 and 2025 increased our production efficiency and speed, while maintaining closer tolerances. We intend to limit capital expenditures until such time as our debt situation is resolved.

 

Cash Provided by Financing Activities

 

For the nine months ended September 30, 2026, cash provided by financing activities was $10,000. During this period, we increased borrowings under our Current Credit Facility by $353,000 (consisting of a net increase in Revolving Loan borrowings of $1,139,000 and a net decrease of $786,000 against the Term Loan). Additionally, we made payments of $179,000 pursuant to finance lease obligations, $28,000 on our Solar Credit Facility, $5,000 on a loan payable and $131,000 for taxes related to the net share settlement of equity awards. 

 

OFF-BALANCE SHEET ARRANGEMENTS

 

We did not have any off-balance sheet arrangements as of September 30, 2026.

 

Critical Accounting Estimates

 

A critical accounting estimate is one that is both important to the portrayal of a company’s financial condition and results of operations and requires management’s most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain.

 

32

 

Use of Estimates. The preparation of financial statements in accordance with generally accepted accounting principles in the U.S. requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The financial statements include estimates based on currently available information and our judgment as to the outcome of future conditions and circumstances. Significant estimates in these financial statements include inventory valuation, useful lives and impairment of long-lived assets, income tax provision, and allowance for credit losses. Changes in the status of certain facts or circumstances could result in material changes to the estimates used in the preparation of the financial statements and actual results could differ from the estimates and assumptions.

 

There have been no material changes to the Company’s critical accounting estimates as compared to the estimates described in the 2025 Annual Report which we believe are the most critical to our business and understanding of our results of operations and affect the more significant judgments and estimates that we use in preparation of our condensed consolidated financial statements.

 

Item 4. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

Our management, with the participation of our Acting Chief Executive Officer (“CEO”) and Vice President of Finance, who is our principal financial and accounting officer (“PFO”), evaluated the effectiveness of our disclosure controls and procedures as defined in Rule 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as of September 30, 2026. Our disclosure controls and procedures are designed to provide reasonable assurance that information we are required to disclose in the reports we file or submit under the Exchange Act is accumulated and communicated to our management, including our CEO and PFO, as appropriate to allow timely decisions regarding required disclosures, and is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms. Based on this evaluation, and as a result of the material weakness described below, our CEO and PFO have concluded that our disclosure controls and procedures were not effective as of September 30, 2026.

 

As reported in our 2025 Form 10-K, in connection with their review of our internal controls as of and for the year ended December 31, 2025, our management identified a material weakness in our internal controls over financial reporting related to our IT systems which has yet to be remediated. During fiscal 2025, we implemented new controls and procedures designed to remediate this weakness but additional enhancements and more formalized documentation are still required. Tests of such controls and procedures are ongoing and the material weakness noted will only be deemed to have been remediated after the new controls and procedures have been in place for a sufficient period and management has concluded through appropriate testing that the controls are operating effectively. As such, we consider this material weakness to not be remediated as of September 30, 2026. Based on this evaluation and as a result of this material weakness, we have concluded that our disclosure controls and procedures were not effective as of September 30, 2026. For more information, see Item 9A. Controls and Procedures, included in our Annual Report on Form 10-K.

 

During 2026, the Company is continuing to test such controls and procedures designed to remediate the aforementioned material weakness.

 

Changes in Internal Control over Financial Reporting

 

Other than as described above, there have not been any changes in our internal control over financial reporting, as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act, during our most recently completed fiscal quarter which is the subject of this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

33

 

PART II

 

OTHER INFORMATION

 

Item 1A. Risk Factors.

 

Investors are encouraged to consider the risks described in our Registration Statement on Form S-4 filed with the SEC on July 22, 2026 and Amendments to the Form S-4 filed on October 2, 2026 and on October 22, 2026 and our 2025 Form 10-K, our Management’s Discussion and Analysis of Financial Condition and Results of Operations contained in this Report and other information publicly disclosed or contained in documents we file with the Securities and Exchange Commission before purchasing our securities.

 

Item 6. Exhibits 

 

Exhibit No.   Description
2.1   Agreement and Plan of Merger by and among Air Industries Group, Tenax Aerospace Acquisition, LLC and Transitory Air Sub LLC (incorporated herein by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K filed February 17, 2026).
     
2.2   Amendment to Agreement and Plan of Merger, dated as of June 8, 2026, among Tenax Aerospace Acquisition, LLC, the Company and Transitory Air Sub LLC (incorporated herein by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed June 12, 2026).
     
2.3   Amended and Restated Agreement and Plan of Merger, dated as of July 2, 2026, among Tenax Aerospace Acquisition, LLC, the Company and Transitory Air Sub LLC (incorporated herein by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K filed July 9, 2026).
     
2.4   Amendment to Amended and Restated Agreement and Plan of Merger dated as of July 31, 2026, among Tenax Aerospace Acquisition, LLC, the Company and Transitory Air Sub LLC (incorporated herein by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K filed August 3, 2026).
     
10.1   Eleventh Amendment to Loan and Security Agreement with Webster Bank, National Association (incorporated herein by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed February 27, 2026).
     
10.2    Twelfth Amendment to Loan and Security Agreement with Webster Bank, National Association (incorporated herein by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed August 24, 2026).
     
10.3   Thirteenth Amendment to Loan and Security Agreement with Webster Bank, National Association (incorporated herein by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed November 10, 2026).
     
10.4   Related Party Notes Extension with Michael Taglich (incorporated herein by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed November 10, 2026).
     
10.5   Related Party Notes Extension with Robert Taglich (incorporated herein by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K filed November 10, 2026).
     
10.6*   Agreement of Modification of Lease dated October 29, 2026.
     
31.1*   Certification of principal executive officer pursuant to Rule 13a-14 or Rule 15d-14 of Securities Exchange Act of 1934.
     
31.2*   Certification of principal financial officer pursuant to Rule 13a-14 or Rule 15d-14 of the Exchange Act of 1934.
     
32.1**   Certification of principal executive officer pursuant to Section 906 of Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350).
     
32.2**   Certification of principal financial officer pursuant to Section 906 of Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350).
     
    XBRL Presentation
     
101.INS   Inline XBRL Instance Document.
     
101.SCH   Inline XBRL Taxonomy Extension Schema Document.
     
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document.
     
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document.
     
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document.
     
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document.
     
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

 

* Filed herewith
** Furnished herewith

 

34

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Dated: November 13, 2026

 

  AIR INDUSTRIES GROUP
     
  By:  /s/ Brian Drisgula
    Brian Drisgula
Vice President of Finance
(principal financial and accounting officer)

 

35

 

Filing Exhibits & Attachments

10 documents

Keep reading